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Abstract 
Despite technological advances in public health informatics, the evaluation of infectious 
disease surveillance systems data remains incomplete. In this study, a thorough 
evaluation was performed of the West Virginia Electronic Disease Surveillance System 
(WVEDSS, 2007-2010) and the West Virginia Electronic Disease Surveillance System – 
NationalEDSS -Based System (WVEDSS-NBS; March 2012 - March 2014) for Category 
II infectious diseases in West Virginia. The purpose was to identify key areas in the 
surveillance system process—from disease diagnosis to disease prevention—that need 
improvement. Grounded in the diffusion of innovation theory, a quasi-experimental, 
interrupted, time-series design was used to evaluate the 2 data sets. Research questions 
examined differences in mean reporting time, the 24-hour standard, and comparison of 
complete fields (DOB, gender etc.) of the data sets using independent samples t tests. The 
study found (a) that the mean reporting times were shorter for WVEDSS compared to 
WVEDSS-NBS (p < .05) for all vaccine-preventable infectious diseases (VPID) in 
Category II except for mumps; (b) that the 24-hour standard was not met for WVEDSS 
compared to WVEDSS-NBS (p < .05) for all VPID in Category II except for mumps, and 
(c) that most fields were complete for WVEDSS compared to WVEDSS-NBS (p < .05) 
for all VPID in Category II except for meningococcal disease. Healthcare professionals in 
the state can use the results of this research to improve the system attributes of timeliness 
and completeness. Implications for positive social change included improved access to 
public health data to better understand health disparities, which, in turn could reduce 
morbidity and mortality within the population.  
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Chapter 1: Introduction to the Study 
Introduction  
There is an increased need for state infectious disease surveillance systems 
(IDSS) to be integrated with the National Electronic Disease Surveillance System 
(NEDSS) and for )the creation of a national electronic health record (EHR) system. Title 
64, Legislative Rule of the West Virginia State Legislature requires health professionals 
to report communicable diseases to their local health department. Prior to March 2012, 
practitioners, hospitals, providers, and laboratories reported infectious diseases to the 
West Virginia Electronic Disease Surveillance System (WVEDSS) by mail or fax. The 
Centers for Disease Control and Prevention (CDC) developed a new system model to 
interface with National Electronic Disease Surveillance System (NEDSS) and EHR. The 
West Virginia Electronic Disease Surveillance System –NationalEDSS Based 
Surveillance (WVEDSS-NBS, Department of Health and Human Resources [DHHR], 
2011) went live in March 2012. Since then, local health departments have required health 
professionals to report infectious diseases via the newly developed WVEDSS-NBS. The 
WVEDSS-NBS, is an electronic disease reporting system for West Virginia hospitals, 
state public health departments, health professionals, laboratories, and local public health 
departments.  
The newly developed WVEDSS-NBS, now on a Web-based server, was 
established to improve the efficiency and accuracy of infectious disease reporting. 
According to Doyle, Glynn, and Groseclose (2002), evaluations of electronic disease 
surveillance systems are insufficient, imperfect, and incomplete. Baker (2010) stated that 
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reviews at the state level organize and identify improvements that can be applied at the 
national level. In this study, I evaluated the old WVEDSS (during the period 2007-2010) 
and the newly developed WVEDSS-NBS (from March 2012 to March 2014) to compare 
and identify system attributes (specifically timeliness and completeness). The results of 
these data are expected to give public health officials the information they need to make 
informed decisions about disease outbreaks. 
 Public health officials rely on the timeliness and completeness of the surveillance 
system data reported by the WVEDSS-NBS to design public policies and interventions. 
According to Baker, Easther, and Wilson (2010) and the World Health Organization’s 
(WHO) International Health Regulations (IHR, 2005), the timeliness of infectious disease 
reporting is an essential component of any evaluation where early intervention is a factor. 
For Category II infectious diseases, healthcare practitioners and public health 
professionals in West Virginia use this research to improve timely reporting, prevention, 
and interventions. Doyle et al. (2002) defined infectious disease mandatory reporting as 
the routine gathering of individual cases to organize timely prevention and interventions 
to control infectious disease outbreaks (p. 1). With accurate and timely reporting, public 
health officials have the data needed to plan, organize, and implement public health 
interventions and policies to prevent and control infectious disease outbreaks in West 
Virginia. In this study, I examined the WVEDSS-NBS for sustainability; I compared 
system attributes using the diffusion of innovation theory as a way to understand the 
scope of the technological innovation, WVEDSS-NBS.  
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Background 
 In a breakthrough 1988 report, the Institute of Medicine (IOM) identified the core 
functions of public health as assessment, policy development, and assurance. Public 
health surveillance falls under the assessment function, which consists of collection of 
surveillance information, management or assembly of surveillance information into data, 
analysis of the data, data interpretation, dissemination, and stimulation. According to 
Thacker, Qualters, and Lee (2012), public health surveillance is the foundation of 
practice in public health and a vital component of the assessment function. A survey was 
conducted by the CDC to establish a baseline for the growth of public health surveillance 
at the agency. Of the 434 individuals who responded to the 2009 Web-based survey, 
nearly 60% stated that surveillance at the CDC is sound; only 33% stated that the CDC 
examines and publishes surveillance data in a timely manner, and only 20% agreed that 
the CDC surveillance systems are adaptable and malleable to the mutable environment of 
health informatics in the 21st century. The CDC outlined six factors to advance public 
health surveillance in the 21st century (Thacker et al., 2012):  
§ A shared lexicon of terms needs to be developed.  
§ Surveillance needs around the world need to be identified.  
§ Informatics concerns and emerging information technologies need to be 
maintained,  
§ A competent workforce needs to be trained. 
§ The analytical concerns of data use and access need to be addressed. 
§ The management, storage, and analysis of data must be organized.  
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All of these factors are discussed here and applied throughout the study by integration 
with the research variables.  
Lexicon   
From surveys, research, and interviews, the CDC developed six factors to advance 
public health surveillance in the 21st century. The principal factor is the lexicon that 
health professionals use in their day-to-day working environments. Many medical terms, 
acronyms, data-source terms, surveillance system modifiers, types of surveillance 
systems, and emerging terms will need to be addressed to design and maintain a national 
system to interact at the local and state levels to integrate the gathered information at the 
international level. Thacker, Qualters, and Lee (2012) emphasized the need for increased 
health situation awareness (Appendix C) and a working knowledge of the theoretical 
flowchart of public health surveillance (Appendix D). All states in the U. S. have laws 
that identify reportable infectious diseases that must be reported to the state.  However, 
the CDC has established notifiable infectious diseases that must be reported to the CDC, 
these notifiable infectious diseases may or may not be reportable to the state.  In order to 
address this variance, the CDC and the Council for State and Territorial Epidemiologists 
(CSTE) published a report outlining specific requirements for case definitions in 1990 
with an update in 1997. The list contains past, current, and future notifiable conditions 
that have been validated by the Association of Public Health Laboratories (APHL) for 
use in public health practice and surveillance. All states are currently using a shared 
lexicon when they use the standard CDC case definitions. 
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Global Surveillance Needs 
 The emergence of new deadly viruses, mutating strains of influenza, and the rise 
of bioterrorism in the last few decades of the 20th century has increased the awareness of 
global public health issues. The WHO orchestrates global public health surveillance 
(much like the CDC organizes the public health concerns within the United States). Each 
country is responsible for monitoring diseases and organizing a response, but the IHR 
2005 is the only mandatory international contract on disease control. The IHR constitute 
an international legal mechanism to incorporate the global public health concerns of 194 
countries, including the Member States of WHO. The IHR was revised in 2005 to include 
more diseases and to extend the regulations to other areas of international public health 
concern. IHR 2005 took effect in June 2007 and requires countries to report infectious 
diseases and other public health events of concern to WHO by disregarding border 
disputes and focusing on the source, control, and prevention of the disease.  The IHR 
2005 defined the responsibilities of member countries and the WHO for public health 
security and surveillance to strengthen their capacity for public health surveillance and 
response at the source of the outbreak. The CDC has been called on to provide technical 
assistance and emphasize important IHR 2005 surveillance requirements at world 
meetings and summits. According to St. Louis (2012), the CDC proposed a vision for 
global public health to incorporate national surveillance systems into a world surveillance 
network. An essential step in this process is creating a shared lexicon for a global 
network of public health and health professionals. To create a social network so that they 
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can communicate among one another and share surveillance data to target disease 
outbreaks in a timely manner. 
Informatics 
Public health informatics is part of a larger field called biomedical or health 
informatics; they both require a thorough knowledge and understanding of the integration 
of technology, information science, and computer science with respect to public health 
and biomedicine. Public health surveillance has used advances and created new 
technologies in informatics to investigate and solve public health problems. Savel and 
Foldy (2012) identified three public health informatics work areas: the investigation and 
explanation of multifaceted systems, the recognition of prospects to enhance the efficacy 
and competence of public health systems through inventive data compilation or the 
application of data, and the application and upkeep of procedures and systems to 
accomplish these enhancements. The evolving field of surveillance informatics must find 
innovative ways to incorporate numerous sources of intricate statistics into significant 
intelligence that enables officials to implement interventions (Savel and Foldy, 2012). 
The investigation, explanation, and integration of multifaceted systems began in 
1951 (Appendix E) when the National Office of Vital Statistics began receiving state data 
by phone and mail. In 1961, the CDC took over and began publishing the Morbidity and 
Mortality Weekly Report (MMWR) with communicable disease information and 
statistics. In 1985, the CDC launched the Electronic Surveillance Project (ESP), a 
national 5-year project. States are charged with developing their own systems while the 
CDC is charged with developing ways to integrate the state data. Thus, the electronic era 
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of public health commenced over 25 years ago. The National Notifiable Diseases 
Surveillance System (NNDSS) includes all aspects of disease surveillance from the local 
to national level. The NNDSS developed the National Electronic Telecommunications 
System for Surveillance (NETSS) in 1990 to incorporate state and national records. 
NETSS was a DOS-based system and in 1995 the Epidemiology Program Office (EPO) 
suggested that an update to NETSS, a Windows-based system. In 1998 an integration 
project was started but stopped in 1999 when the CDC Office of the Director’s 
Information Resource Management Office created NEDSS. 
NEDSS was developed to incorporate local, state, and national electronic 
surveillance systems and simplify the transfer of electronic data. The EPO and NETSS 
are still the primary sources of surveillance in 2012. In 2000 the CDC provided states 
with funding through the Epidemiology Laboratory Capacity (ELC) cooperative 
agreement and the CDC developed the NEDSS Base System (NBS), a platform for states 
to begin electronic surveillance by utilizing detailed disease modules. In 2004, the CDC 
created the Public Health Information Network (PHIN) to broaden the scope of NEDSS 
surveillance and the EPO moved to the new Division of Public Health Informatics. The 
next year, 27 health departments entered data using the Internet-based systems and 26 
jurisdictions received lab results via electronic laboratory reporting (ELR). In 2008, the 
CDC and NNDSS received the first Health Level Seven (HL7) messages for disease case 
notifications. The HL7 was developed to incorporate clinical and laboratory data into 
NEDSS. The CDC reorganized in 2009 by establishing the Office of Surveillance, 
Epidemiology, and Laboratory Services. As of 2011, every state used NEDSS-compliant 
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surveillance systems and one-third used the NBS. Currently, the CDC receives case 
notifications from 57 jurisdictions. One of these jurisdictions is the state of West 
Virginia. The WVEDSS was established in 2007 and in March 2012 was converted to the 
WVEDSS-NBS. 
Skilled Workforce 
In order to keep up with the challenges of national and international public health 
surveillance, the initial education of new recruits, training, and continuing education of 
the growing surveillance workforce is a necessity. According to Drehobl, Roush, Stover, 
and Koo (2012), the education of the workforce has not kept up with the expansion of 
public health in the 21st century. The American Recovery and Reinvestment Act (ARRA) 
of 2009 and the 2010 Patient Protection and Affordable Care Act (ACA) provided 
opportunities for the country to increase and educate the public health workforce. The 
ARRA provided $50 million to offset budget cuts in state and local public health 
departments and the ACA has the initiative to increase the public health workforce and 
expand grants to public health surveillance related activities. A sufficient, cultivated, well 
informed, and competent health workforce that is prepared to use the appropriate tools is 
fundamental for a successful public health surveillance system.  
Data Access and Usage  
 A public health grid (see Appendix F) was used to illustrate the complex nature of 
data access and usage within surveillance systems. The grid contains five main hubs 
consisting of public health departments, providers, consumers, federal agencies, and 
health information exchange. Within this network, information can be shared securely 
9 
 
and privately. Thacker, Qualters, and Lee (2012) indicated that 77% of the CDC’s survey 
respondents replied that a more timely system of information sharing is required for 
future development. The grid provides access points and the interrelationship between 
hubs in the public health network. 
Data Management, Storage, and Analysis 
 Examining the scientific evidence and applying this knowledge to infectious 
disease epidemiology establishes the foundation of effective disease control. In this day 
and time, this evidence must be extracted and translated from mountains of data. 
Surveillance is the process of collecting, organizing, and analyzing this data to make 
health care decisions. Rolka, Walker, English, Katzoff, Scogin, and Neuhaus (2012) 
stated that to achieve surveillance goals, an analytical process must be followed, the 
process requires hardware and software design, programming, statistical analysis, topic 
proficiency, creating models, and successful communication. The ability to translate pure 
data sets into epidemiological facts about diseases to policy makers is imperative for 
successful surveillance systems. 
Purpose of the Study 
The purpose of this study was to identify key areas in the process, from disease 
diagnosis, to disease prevention in order to improve the surveillance system. A major 
limitation among the variables was the reporting behavior of the patients and identifying 
where in the reporting process this behavior should occur. This clearly indicated an 
opportunity for public health officials to develop education and awareness programs in 
this area. Yoo, Park, Park, Lee, Jeong, Lee, & Cho (2009) stated that the most frequent 
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measures that affect disease reporting are disease onset, going to the physician, and 
recording the diagnosis. Yoo et al. further stated that WHO has issued extensive 
guidelines on the evaluation and examination of the steps in the surveillance process.  
Healthcare practitioners and public health professionals in the state use this data to 
improve the system attributes of timeliness and completeness. The difference between 
mean reporting times and the 24-hour standard between the two data sets was evaluated 
for timeliness. The required fields were assessed for completeness. Nicolay, Garvey, 
Delappe, Cormican, and McKeown (2010) stated that the completeness of the essential 
fields on intake forms could affect the sensitivity—and therefore the efficiency—of the 
system. 
Problem Statement 
 
The problem addressed in this study was the incomplete evaluation of the 
reporting of infectious disease surveillance systems data. Doyle et al. (2002) conducted a 
quantitative study to determine disease completeness in the United States. They found 
that the completeness of infectious disease reporting was related to the disease being 
reported. Doyle et al. clarified that underreporting by health professionals and 
laboratories may be related to deficits in knowledge of the legal requirement to report, 
what diseases to report, how to report diseases, and the consequences of not reporting. To 
address this problem, the WVEDSS and the WVEDSS-NBS system attributes (timeliness 
and completeness) were compared, and the results evaluated, to recognize and make 
improvements in the monitoring and evaluation process. The scope of the system, system 
attributes, and existing flaws were examined in order to clarify and address the social, 
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structural, technological, and environmental atmosphere that include the complexities of 
technological innovations, such as electronic infectious disease surveillance systems and 
electronic health records. This study used the system attributes of timeliness and 
completeness to identify areas in need of improvement. 
To examine the gap of incomplete evaluation of the reporting of infectious disease 
surveillance system data, WVEDSS was divided into separate levels in order to ascertain 
at what level problems, errors, and nonconformity arose. Nicolay et al. (2010) suggested 
that an evaluation of surveillance systems data should include timeliness, completeness, 
sensitivity, positive predictive value, and case definitions.  Greenhalgh et al. (2008) stated 
that shared electronic records are multifaceted systems and all stakeholders and their 
practices must accept improvements before the system can run smoothly and efficiently. 
Rogers (1995) stated that the diffusion of innovation model encompasses these levels and 
further subdivides them into specific definitions and organizational elements. Electronic 
disease surveillance systems are intricate innovations that must be accepted, adopted, and 
integrated into the daily workload of all participants in the organization. Greenhalgh et al. 
(2008) illustrated that the more complex the technology behind an innovation, the greater 
the chances of its failure. The importance of this study was that it identified key areas in 
the process, from disease diagnosis to disease prevention, in order to pinpoint steps in the 
process where data may be missing. 
If communicable diseases are consistently being missed, then a different method 
for collection of this data is essential for infectious disease prevention and response to 
outbreaks. The key variables in this study (timeliness and completeness) were essential to 
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identifying the basic structural problems in disease reporting. According to Baker et al. 
(2010), evaluating surveillance systems has the added benefit of locating gaps or areas 
where information is lost in the system. A clear definition of the steps in the process of 
infectious disease surveillance is the primary action in improving the overall performance 
of the system. Thacker, Berkelman, and Stroup (1989) suggested that the best way to 
accomplish this task is to list the uses of the system and then translate those into goals. 
Baker et al. (2010) listed the definition of public health surveillance as “the ongoing 
systematic collection, analysis, interpretation and dissemination of data regarding a 
health-related event for use in public health action to reduce morbidity and to improve 
health” (p. 2).  Essential to the elimination and control of infectious diseases in West 
Virginia and the United States are the timely reporting of diseases, and complete accurate 
data (Averhoff et al., 2006). The objective of this study was to examine these system 
attributes to ensure that accurate and timely data are being collected for the system. 
The objective of this study after examination was complete was to establish 
baseline standards for disease comparison across state lines in the United States and to 
establish current levels of infectious diseases within West Virginia.  Averhoff et al. 
(2006) evaluated the U.S. level of proficiency in detecting endemic rubella transmission 
and that rubella might have been eliminated in America. They stated that rubella 
detection in the United States is sensitive but that there are no standards to compare this 
data across the country. Evaluating the system attributes of timeliness and completeness 
identified missing data essential for the local health department to make policy decisions. 
The study was based on the following three objectives: 
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1. To use the two data sets to calculate the mean reporting time and identify 
differences among Category II infectious diseases in West Virginia. 
2. To use the two data sets to determine the time difference above or below the 
24-hour standard of the Category II infectious diseases in West Virginia. 
3. To examine the intake forms on a case-by-case basis for the required fields 
(identifier, dob, gender, state, county, identifier for reporting facility, program 
area, jurisdiction, date received by public health, specimen source, date 
specimen collected, resulted test, organism, add test result button) of the two 
data sets to determine the baseline for reporting completeness for Category II 
infectious diseases in West Virginia.  
Research Questions  
This study examined the following three research questions. 
1. Is there a difference in mean reporting time of Category II reportable 
infectious diseases between the two data systems (WVEDSS & WVEDSS-
NBS) in West Virginia?  
H01 - There is no difference in mean reporting time of Category II infectious 
diseases between WVEDSS and WVEDSS-NBS.  
Hₐ1 - There is a difference in mean reporting time of Category II infectious 
diseases between WVEDSS and WVEDSS-NBS.  
2. Is there a difference from the 24-hour standard (time delay) of the infectious 
diseases under Category II of the West Virginia reportable infectious diseases 
for both data sources? 
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H02 - There is no difference from the 24-hour standard for one or both data 
sources.  
Hₐ2 - There is a difference from the 24-hour standard for one or both data 
sources.  
3. Are the required fields (Identifier, DOB, Current Sex, State, County, 
Reporting Facility Identifier, Program Area, Jurisdiction, Date Received by 
Public Health, Specimen Source, Date Specimen Collected, Resulted Test, 
Organism, Add Test Result Button) complete for both data sources? 
H03 - There is no difference in completeness of the required fields for one or 
both data sets. 
Hₐ3 - There is a difference in completeness of the required fields for one or 
both data sets. 
Theoretical Framework for the Study 
The diffusion of innovation theory was used to describe the scope of the study and 
to establish the foundation for the dissemination of the WVEDSS-NBS. Everett Rogers 
developed the diffusion of innovation theory several decades ago and it provides a 
“hypothetical scenario of what usually happens when information is spread into a 
population” (Bauman, Nelson, Pratt, Matsudo, and Schoeppe’s, 2006, p. 57). Healthcare 
surveillance systems are multifaceted and encompass managerial, technical, privacy, and 
security aspects that must be processed, adopted, and mastered by individuals and groups 
within the system. 
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To address innovation in the surveillance system, several essential components of 
WVEDSS-NBS structure were examined and evaluated using the diffusion of innovation 
theory. These data was used to establish baselines to assess WVEDSS’s timeliness and 
completeness. The theory matched this research because it provided the examiner with 
the capacity to look at the surveillance system as a whole and the ability to examine 
system attributes on a case-by-case basis. An organization may be prepared for 
innovation overall but still unequipped for a specific innovation, especially a 
technologically based innovation. Rogers (1995) understood that an organization must 
achieve a state of system coherence to accept or reject the innovation. A prospective 
innovation that is successfully embraced in an organization will have the following 
attributes:  apprehension for the transformation process, the ability of the innovation to 
incorporate into the existing scheme, and evaluation of the consequences of 
implementing the innovation. An organization must be prepared at all respective levels in 
order for the innovation to be successfully incorporated and maintained. The theoretical 
foundation will be discussed in more detail in Chapter 2. 
Nature of the Study 
This study used quantitative methods to perform a comparative study of the 
infectious disease reports that were manually entered into WVEDSS between 2007 and 
2010 to the infectious disease reports reported by Web-based server on the newly 
developed WVEDSS-NBS, which was established from March 2012 to March 2014. The 
research design was a quasi-experimental, interrupted time-series design with non-
random assignment of groups. Timeliness was assessed by the difference in mean 
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reporting times and the 24-hour standard reporting time, using the two independent 
samples t tests. The required fields (Identifier, DOB, Current Sex, State, County, 
Identifier for Reporting Facility, Program Area, Jurisdiction, Date Received by Public 
Health, Specimen Source, Date Specimen Collected, Resulted Test, Organism, Add Test 
Result Button) were evaluated for completeness using the two independent samples t 
tests.  
Definitions 
Definitions include an example of different infectious diseases specific to 
Category II of the West Virginia Reportable Infectious Diseases (Table 1), certain aspects 
of the diffusion of innovation theory, timeliness, completeness, sensitivity, and positive 
predictive value. 
Table 1 
 
Category II Infectious Diseases (WVDHHR, 2014) 
 Category	  II	  Infectious	  Diseases	   	  	  Clinical	  Description	  
	  	  Case	  Definition	  Probable	  
	  	  Case	  Definition	  Confirmed	  
	  	  Laboratory	  Evidence	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haemophilus	  influenza,	  invasive	  disease	  
Invasive	  disease	  may	  manifest	  as	  pneumonia,	  bacteremia,	  meningitis,	  epiglottitis,	  septic	  arthritis,	  cellulitis,	  or	  purulent	  pericarditis,	  less	  common	  are	  endocarditis	  and	  osteomyelitis.	  
Meningitis	  with	  detection	  of	  haemophilus	  influenza	  type	  b	  antigen	  in	  cerebrospinal	  fluid	  (CSF).	  	  
Isolation	  of	  	  haemophilus	  influenza	  from	  a	  normally	  sterile	  body	  site.	  
Detection	  of	  H.	  Influenza	  type	  b	  in	  blood	  or	  CSF	  or	  less	  commonly	  joint,	  pleura,	  or	  pericardial	  fluid.	  Positive	  antigen	  test	  results	  from	  urine	  or	  serum	  samples	  are	  unreliable	  for	  diagnosis	  of	  H.	  influenza	  disease.	  	  hepatitis	  A,	  acute	   hepatitis	  A	  is	  a	  viral	  illness	  that	  results	  in	  jaundice,	  fever,	  and	  loss	  of	  appetite,	  nausea,	  malaise,	  and	  sometimes	  diarrhea.	  Affected	  individuals	  may	  have	  abdominal	  pain,	  an	  enlarged	  liver,	  dark	  urine,	  and	  light	  stool.	  The	  majority	  of	  infected	  infants	  and	  preschool	  children	  have	  no	  signs	  or	  symptoms	  of	  the	  disease;	  however,	  they	  are	  just	  as	  infectious	  as	  adults.	  In	  contrast	  to	  hepatitis	  B	  and	  C,	  fulminant	  disease	  or	  death	  
An	  acute	  illness	  with	  discrete	  onset	  of	  any	  sign	  or	  symptom	  consistent	  with	  acute	  viral	  hepatitis	  (fever,	  headache,	  malaise,	  anorexia,	  nausea,	  vomiting,	  diarrhea,	  and	  abdominal	  pain)	  and	  either	  a)	  jaundice	  or	  b)	  elevated	  serum	  	  aminotransferase	  (ALT	  or	  AST)	  levels.	  
A	  case	  that	  meets	  the	  clinical	  definition	  is	  laboratory	  confirmed.	  And	  is	  not	  known	  to	  have	  chronic	  hepatitis	  B.	  OR	  A	  case	  that	  meets	  the	  clinical	  case	  definition	  who	  has	  laboratory-­‐confirmed	  hepatitis	  A	  (i.e.,	  household	  or	  sexual	  contact	  with	  an	  infected	  person	  during	  the	  15-­‐20	  days	  before	  the	  onset	  of	  symptoms.	  
Immunoglobulin	  M	  (IgM)	  antibody	  to	  hepatitis	  A	  virus	  	  (anti-­‐HAV)	  positive.	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occurs	  only	  rarely,	  and	  there	  is	  no	  carrier	  state.	  Severe	  disease	  is	  more	  likely	  to	  occur	  in	  the	  elderly	  or	  in	  persons	  with	  underlying	  liver	  disease	  (including	  hepatitis	  C);	  however,	  complete	  recovery	  is	  the	  rule.	  hepatitis	  B,	  acute	   An	  acute	  illness	  with	  discrete	  onset	  of	  any	  sign	  or	  symptom	  consistent	  with	  acute	  viral	  hepatitis	  (fever,	  headache,	  malaise,	  anorexia,	  nausea,	  vomiting,	  diarrhea,	  and	  abdominal	  pain)	  and	  either	  a)jaundice	  or	  b)	  elevated	  serum	  alanine	  aminotransferase	  (ALT)	  levels	  >	  100	  IU/L	  
Persons	  who	  have	  chronic	  hepatitis	  or	  persons	  identified	  as	  HBsAg	  positive	  should	  not	  be	  reported	  as	  having	  acute	  viral	  hepatitis	  unless	  they	  have	  evidence	  of	  an	  acute	  illness	  compatible	  with	  viral	  hepatitis	  (with	  the	  exception	  of	  perinatal	  hepatitis	  B	  infection).	  
A	  case	  that	  meets	  the	  clinical	  definition	  is	  laboratory	  confirmed.	  And	  is	  not	  known	  to	  have	  chronic	  hepatitis	  B.	  
IgM	  antibody	  to	  hepatitis	  B	  core	  antigen	  (anti-­‐HBc)	  positive	  or	  hepatitis	  B	  surface	  antigen	  (HbsAg)	  positive.	  	  IgM	  anti-­‐HAV	  negative	  (if	  done).	  	  	  
pertussis	   Whooping	  cough	  usually	  starts	  with	  cold	  or	  flu-­‐like	  symptoms,	  such	  as	  runny	  nose,	  sneezing,	  fever	  and	  a	  mild	  cough.	  These	  symptoms	  can	  last	  up	  to	  two	  weeks	  and	  are	  
In	  the	  absence	  of	  a	  more	  likely	  diagnosis,	  a	  cough	  illness	  lasting	  >	  2	  weeks,	  with	  at	  least	  one	  of	  the	  following	  symptoms:	  
• Paroxysms	  of	  coughing;	  or	  
• Inspiratory	  
Acute	  cough	  illness	  of	  any	  duration,	  with	  isolation	  of	  B.	  pertussis	  from	  a	  clinical	  specimen;	  OR	  Cough	  illness	  lasting	  >	  2	  weeks,	  with	  at	  
The	  culture	  is	  the	  gold	  standard	  for	  diagnosis	  of	  
bordetella	  
pertussis.	  All	  suspected	  cases	  of	  pertussis	  should	  have	  a	  nasopharyngeal	  aspirate	  or	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followed	  by	  increasingly	  severe	  coughing	  spells.	  Fever,	  if	  present,	  is	  usually	  mild.	  The	  clinical	  course	  is	  divided	  into	  three	  stages:	  	  
Catarrhal	  Stage:	  Characterized	  by	  insidious	  onset	  of	  coryza	  (runny	  nose),	  sneezing,	  low-­‐grade	  fever,	  and	  a	  mild,	  occasional	  cough,	  similar	  to	  the	  common	  cold.	  The	  cough	  gradually	  becomes	  more	  severe,	  and	  after	  1-­‐2	  weeks,	  the	  second	  or	  paroxysmal	  stage,	  begins.	  Patients	  with	  pertussis	  are	  most	  infectious	  from	  the	  beginning	  of	  the	  catarrhal	  stage	  through	  the	  3rd	  week	  after	  the	  onset	  of	  paroxysms.	  	  
Paroxysmal	  
Stage:	  Characterized	  by	  bursts,	  or	  paroxysms	  of	  numerous,	  rapid	  coughs,	  apparently	  due	  to	  difficulty	  expelling	  thick	  
“whoop”;	  or	  
• Post-­‐tussive	  vomiting	  AND	  
• Absence	  of	  laboratory	  confirmation	  
• No	  epidemiologic	  linkage	  to	  a	  laboratory	  confirmed	  case	  of	  pertussis.	  
least	  one	  of	  the	  following	  symptoms:	  
• Paroxysms	  of	  coughing;	  or	  
• Inspiratory	  “whoop”;	  or	  
• Post-­‐tussive	  vomiting	  AND	  
• Polymerase	  chain	  reaction	  (PCR)	  positive	  for	  pertussis;	  Illness	  lasting	  >2	  weeks,	  with	  at	  least	  one	  of	  the	  following	  symptoms:	  
• Paroxysms	  of	  coughing;	  or	  
• Inspiratory	  “whoop”;	  or	  
• Post-­‐tussive	  vomiting	  AND	  
• Contact	  with	  a	  laboratory	  confirmed	  case	  of	  pertussis.	  
swab	  obtained	  for	  culture	  from	  the	  posterior	  nasopharynx.	  
20 
 
mucous	  from	  tracheobronchial	  tree.	  At	  the	  end	  of	  the	  paroxysm,	  a	  long	  inspiratory	  effort	  is	  usually	  accompanied	  by	  a	  characteristic	  high-­‐pitched	  whoop.	  During	  such	  an	  attack,	  the	  patient	  may	  become	  cyanotic	  (turn	  blue).	  Vomiting	  and	  exhaustion	  commonly	  follow	  the	  episode.	  The	  patient	  usually	  appears	  normal	  between	  attacks.	  The	  paroxysms	  can	  occur	  more	  frequently	  at	  night.	  	  
Convalescent	  
Stage:	  Characterized	  by	  gradual	  recovery.	  The	  cough	  becomes	  less	  paroxysmal	  and	  disappears	  over	  2-­‐3	  weeks.	  However	  paroxysms	  often	  recur	  with	  subsequent	  viral	  respiratory	  infections	  for	  many	  months	  after	  the	  onset	  of	  pertussis.	  Older	  persons	  (i.e.,	  adolescents	  and	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adults),	  and	  those	  partially	  protected	  by	  the	  vaccine,	  may	  become	  infected	  with	  B.	  pertussis,	  but	  usually	  have	  milder	  disease.	  Pertussis	  in	  these	  persons	  may	  present	  as	  a	  persistent	  (<7	  days)	  cough,	  and	  may	  be	  indistinguishable	  from	  other	  upper	  respiratory	  infections.	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rabies,	  Human	   The	  incidence	  of	  animal	  bites	  is	  considerably	  higher	  among	  children,	  particularly	  those	  five	  to	  nine	  years	  of	  age	  4-­‐6.	  Incidence	  decreases	  as	  age	  increases.	  Injuries	  inflicted	  by	  dogs	  are	  most	  common	  (80-­‐90%),	  with	  cats	  being	  the	  next	  most	  common	  species	  involved3,	  4.	  Doberman	  pinschers,	  German	  shepherds,	  and	  pit	  bull	  terriers	  are	  the	  most	  common	  purebred	  canines	  implicated	  in	  fatal	  attacks.	  	  	  Rabies	  is	  an	  acute	  encephalomyelitis	  that	  almost	  always	  progresses	  to	  coma	  or	  death	  within	  10	  days	  after	  the	  first	  symptom.	  Rabies	  virus	  belongs	  to	  the	  order	  mononegavirales,	  viruses	  with	  non-­‐segmented,	  negative-­‐
Human	  Exposure	  	  A	  bite	  or	  scratch	  from	  a	  vector	  species	  or	  the	  introduction	  of	  saliva	  or	  central	  nervous	  system	  (CNS)	  tissue	  from	  a	  vector	  species	  into	  an	  open,	  fresh	  wound	  or	  mucous	  membrane	  (	  eye,	  mouth,	  or	  nose)	  of	  a	  human	  being.	  	  	  
Vector	  Species	  	  Species	  include	  bats	  or	  terrestrial	  mammals,	  especially	  carnivores.	  Wild	  
species	  known	  to	  be	  reservoirs	  of	  rabies	  include,	  but	  are	  not	  limited	  to,	  raccoons,	  skunks,	  foxes,	  coyotes,	  bobcats,	  wolves,	  or	  any	  hybrids	  between	  these	  wild	  species	  and	  domestic	  dogs	  and	  cats.	  	  
Domestic	  species	  include,	  but	  are	  not	  limited	  to,	  dogs,	  cats,	  and	  ferrets.	  
A	  clinically	  confirmed	  case	  that	  is	  laboratory	  confirmed	  by	  testing	  at	  a	  state	  or	  federal	  public	  health	  laboratory.	  
• Detection	  of	  lyssavirus	  antigens	  in	  a	  clinical	  specimen	  (preferably	  the	  brain	  or	  the	  nerves	  surrounding	  hair	  follicles	  in	  the	  nape	  of	  the	  neck)	  by	  direct	  fluorescent	  antibody	  test,	  or	  
• Isolation	  (in	  cell	  culture	  or	  in	  laboratory	  animal)	  of	  a	  lyssavirus	  from	  saliva	  or	  CNS	  tissue;	  or	  
• Identification	  of	  lyssavirus	  specific	  antibody	  (i.e.	  by	  indirect	  fluorescent	  antibody	  (IFA)	  test	  or	  complete	  rabies	  virus	  neutralization	  at	  1:5	  dilution)	  in	  the	  serum	  of	  an	  unvaccinated	  person;	  or	  
• Detection	  of	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stranded	  RNA	  genomes.	  Within	  this	  group,	  viruses	  with	  a	  distinct	  "bullet"	  shape	  are	  classified	  in	  the	  
rhabdoviridae	  family;	  which	  includes	  at	  least	  three	  genera	  of	  animal	  viruses,	  
lyssavirus,	  
ephemerovirus,	  and	  vesiculovirus.	  The	  genus	  
lyssavirus	  includes	  the	  rabies	  virus10.	  
lyssavirus	  viral	  RNA	  (using	  reverse	  transcriptase-­‐polymerase	  chain	  reaction	  [RT-­‐PCR}	  in	  saliva,	  CSF,	  or	  tissue.	  
	  	  	  	  	  rubella	   Rubella	  is	  a	  viral	  illness	  caused	  by	  a	  togavirus	  of	  the	  genus	  rubivirus	  and	  is	  characterized	  by	  a	  mild,	  maculopapular	  rash.	  The	  rubella	  rash	  occurs	  in	  50%–80%	  of	  rubella-­‐infected	  persons	  and	  is	  sometimes	  misdiagnosed	  as	  measles	  or	  scarlet	  fever.	  Children	  usually	  develop	  few	  or	  no	  constitutional	  symptoms,	  but	  adults	  may	  experience	  a	  1–5-­‐day	  prodrome	  of	  low-­‐grade	  fever,	  headache,	  malaise,	  mild	  coryza,	  and	  
In	  the	  absence	  of	  a	  more	  likely	  diagnosis,	  an	  illness	  characterized	  by	  all	  of	  the	  following:	  
• Acute	  onset	  of	  generalized	  maculopapular	  rash;	  and	  
• Temp.	  >	  99.0⁰F	  or	  37.2⁰C;	  and	  
• Arthralgia,	  arthritis,	  lymphadenopathy,	  or	  conjunctivitis;	  and	  
• Lack	  of	  epidemiologic	  linkage	  to	  a	  laboratory-­‐confirmed	  case	  of	  rubella;	  and	  
• Noncontributory	  or	  no	  serologic	  or	  
A	  case	  with	  or	  without	  symptoms	  who	  has	  laboratory	  evidence	  of	  rubella	  infection	  confirmed	  by	  one	  or	  more	  of	  the	  following	  laboratory	  tests:	  
• Isolation	  of	  rubella	  virus;	  or	  
• Detection	  of	  rubella-­‐virus	  specific	  nucleic	  acid	  by	  polymerase	  chain	  reaction;	  or	  
• Significant	  rise	  between	  acute-­‐	  and	  convalescent-­‐phase	  titers	  in	  serum	  rubella	  
Rubella	  virus	  can	  be	  detected	  from	  nasal,	  throat,	  urine,	  blood,	  and	  cerebrospinal	  fluid	  specimens	  from	  persons	  with	  rubella.	  The	  best	  results	  come	  from	  throat	  swabs.	  Cerebrospinal	  fluid	  specimens	  should	  be	  reserved	  for	  persons	  with	  suspected	  rubella	  encephalitis.	  Efforts	  should	  be	  made	  to	  obtain	  clinical	  specimens	  for	  virus	  detection	  from	  all	  case-­‐patients	  at	  the	  time	  of	  the	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conjunctivitis.	  Postauricular,	  occipital	  and	  posterior	  cervical	  lymphadenopathy	  is	  characteristic	  and	  precedes	  the	  rash	  by	  5–10	  days.	  Arthralgia	  or	  arthritis	  may	  occur	  in	  up	  to	  70%	  of	  adult	  women	  with	  rubella.	  Rare	  complications	  include	  thrombocytopenic	  purpura	  and	  encephalitis.	  Rubella	  is	  transmitted	  through	  direct	  or	  droplet	  contact	  from	  nasopharyngeal	  secretions	  and	  has	  an	  average	  incubation	  period	  of	  17	  days	  (range:	  12–23	  days).	  Persons	  with	  rubella	  are	  most	  infectious	  when	  rash	  is	  erupting,	  but	  they	  can	  shed	  viruses	  from	  7	  days	  before	  to	  7	  days	  after	  rash	  onset.	  When	  rubella	  infection	  occurs	  during	  pregnancy,	  especially	  during	  
virology	  testing.	   immunoglobulin	  G	  antibody	  level	  by	  any	  standard	  serologic	  assay;	  or	  
• Positive	  serologic	  test	  for	  rubella	  immunoglobulin	  M	  (IgM)	  antibody;	  OR	  An	  illness	  characterized	  	  by	  all	  of	  the	  following:	  
• Acute	  onset	  of	  generalized	  maculopapular	  rash;	  and	  
• Temp.	  >	  99.0⁰F	  or	  37.2⁰C;	  and	  
• Arthralgia,	  arthritis,	  lymphadenopathy,	  or	  conjunctivitis;	  and	  
• epidemiologic	  linkage	  to	  a	  laboratory-­‐confirmed	  case	  of	  rubella	  
initial	  investigation.	  Virus	  may	  be	  detected	  from	  1	  week	  before	  to	  2	  weeks	  after	  rash	  onset.	  However,	  maximum	  viral	  shedding	  occurs	  up	  to	  day	  4	  after	  rash	  onset.	  Real-­‐time	  RT-­‐PCR	  and	  RT-­‐PCR	  can	  be	  used	  to	  detect	  rubella	  virus	  and	  has	  been	  extensively	  evaluated	  for	  its	  usefulness	  in	  detecting	  rubella	  virus	  in	  clinical	  specimens.	  Clinical	  specimens	  obtained	  for	  virus	  detection	  and	  sent	  to	  CDC	  are	  routinely	  screened	  by	  these	  techniques.	  Molecular	  typing	  is	  recommended	  because	  it	  provides	  important	  epidemiologic	  information	  to	  track	  the	  epidemiology	  of	  rubella	  in	  the	  United	  States	  now	  that	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the	  first	  trimester,	  serious	  consequences	  can	  result.	  These	  include	  miscarriages,	  fetal	  deaths/stillbirths,	  and	  a	  constellation	  of	  severe	  birth	  defects	  known	  as	  congenital	  rubella	  syndrome	  (CRS).	  The	  most	  common	  congenital	  defects	  are	  cataracts,	  heart	  defects	  and	  hearing	  impairment.	  
rubella	  virus	  no	  longer	  continuously	  circulates	  in	  this	  country.	  By	  comparing	  virus	  sequences	  obtained	  from	  new	  case-­‐patients	  with	  other	  virus	  sequences,	  the	  origin	  of	  particular	  virus	  types	  in	  this	  country	  can	  be	  tracked.	  Furthermore,	  this	  information	  may	  help	  in	  documenting	  the	  maintenance	  of	  the	  elimination	  of	  endemic	  transmission.	  In	  addition,	  genotyping	  methods	  are	  available	  to	  distinguish	  wild-­‐type	  rubella	  virus	  from	  vaccine	  virus.	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Definitions 
 
 Case Definition: A case definition is set of uniform criteria used to define a 
disease for public health surveillance. Case definitions enable public health to classify 
and count cases consistently across reporting jurisdictions, and should not be used by 
healthcare providers to determine how to meet an individual patient’s health needs. 
(CDC, 2013) 
 Communication: A process in which participants create and share information 
with one another in order to reach a mutual understanding. Diffusion is a particular type 
of communication in which the message content that is exchanged is concerned with a 
new idea. (Rogers, 2003, p. 18) 
Communication channel: The means by which messages get from one individual 
to another. (Rogers, 2003, p. 18) 
Completeness or data quality: Data quality reflects the completeness and validity 
of the data recorded in the public health surveillance system. Examining the percentage 
of blank "required" responses to items on surveillance forms is a straightforward and easy 
measure of data quality. (CDC, 2011, p. 407) 
Diffusion: The process in which an innovation is communicated through certain 
channels over time among the members of a social system. (Rogers, 2003, p. 11) 
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Diffusion of Innovation Theory: The diffusion model is a conceptual paradigm 
with relevance for many disciplines. The multidisciplinary nature of diffusion research 
cuts across various scientific fields. A diffusion approach provides a common conceptual 
ground that bridges these divergent disciplines and methodologies.  (Rogers, 2003, p. 
103-104) 
Dissemination: Diffusion that is directed and managed.  (Rogers, 2003, p. 7) 
Innovation: An idea, practice, or object perceived as new by an individual or other 
unit of adoption.  (Rogers, 2003, p. 12) 
Positive Predictive Value (PPV): The proportion of persons identified as having 
cases that actually do have the condition under surveillance. (CDC, 2011, p. 407) 
Sensitivity: The sensitivity of a surveillance system can be considered on two 
levels. First, at the level of case reporting, sensitivity refers to the proportion of cases of a 
disease (or other health-related event) detected by the surveillance system (43). Second, 
sensitivity can refer to the ability to detect outbreaks, including the ability to monitor 
changes in the number of cases over time. (CDC, 2011, p. 407) 
Social Change: The process by which alteration occurs in the structure and 
function of a social system. (Rogers, 2003, p. 6) 
Technology: A design for instrumental action that reduces the uncertainty in the 
cause-effect relationships involved in achieving a desired outcome.  (Rogers, 2003, p. 13) 
Time: Time is involved in diffusion in (1) the innovation-diffusion process, (2) 
innovativeness, and (3) an innovation’s rate of adoption.  (Rogers, 2003, p. 37) 
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Timeliness: Timeliness reflects the speed between steps in a public health 
surveillance system (CDC, 2011, p. 407) 
Uncertainty: The degree to which a number of alternatives are perceived with 
respect to the occurrence of an event and the relative probability of these alternatives  
(Rogers, 2003, p. 6). 
 
Assumptions 
The major assumption was that all data had been reported accurately for both 
surveillance systems within the times specified, WVEDSS (2007-2010) and WVEDSS-
NEDSS (March 2012-March 2014). 
Scope and Delimitations 
The West Virginia state epidemiology office was contacted for permission to 
evaluate all Category II infectious disease data reported within the specified time frame. 
Category II infectious diseases were included in the study and not Category I, III, IV, or 
V infectious diseases. I worked with the West Virginia state epidemiology office to 
determine which cases of Category II infectious diseases in West Virginia to examine to 
achieve more power for the analysis. The system attributes of timeliness and 
completeness were covered, but not sensitivity and positive predictive value.  
The sample size, which included over 1000 cases of infectious disease from the 
entire state, increased the reliability of the sample. Lee and Baskerville (2003) explained 
that to increase the reliability of a random sample the size of the sample must be 
increased. Increasing the sample size reaffirms what has been uncovered in the sample 
but does not allow the sample findings to be generalized to the population. Increasing the 
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sample size does increase the level of statistical significance and the generalizability of 
the sample to other samples, but not to the population being studied or to the rejection or 
acceptance of the null hypothesis. This sampling procedure does reduce the likelihood of 
a Level I error. The only scientifically acceptable way to generalize a theory in a new 
setting is for the theory to persist in an experiential test in that setting. 
Limitations 
 The entire state is required to submit their reportable cases to their local health 
departments. The limitation for this study is that secondary data will be collected from 
the past from two different time periods.  Creswell (2009) stated that limitations in data 
not collected for research purposes or data collected in the past are that it can be 
incomplete, inaccurate, have selection bias, and many other variables that are unknown to 
the researcher. Limitations from using data from two different time periods can be that 
cases are not randomized, pre- and post- groups may not have the same characteristics, 
others factors may indicate confounding bias (Creswell, 2009). According to Harris, 
Bradham, Baumgarten, Zuckerman, Fink, and Perencevich (2004) the nonrandom nature 
of a quasi-experimental design is its major weakness.  The data in this study will selected 
by convenience and will include all data entered for the time periods specified. 
 Other weaknesses in the study design were regression to the mean and maturation 
effects.  Regressions to the mean and maturation effects were both threats to internal 
validity in this study. Regression to the mean was a possible threat because the 
intervention may or may not have been the reason for an improvement in surveillance. 
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Maturation effects were a possible threat in concluding that the intervention caused an 
improvement in reporting.  
 A major weakness in regard to the variables was the reporting behavior of the 
patients and in identifying where in the reporting process this behavior occurs.  The 
reporting behavior of the patients is only attributable to the date of disease onset.  Since 
timeliness was measured from diagnosis date to report date this clears the patients 
reporting behavior as a limitation to the study.  This clearly indicates an opportunity for 
public health officials to develop education and awareness programs.  
Social Change Implications 
The results of this study may provide health departments with the information and 
tools to address the fundamental factors that help public health officials assess the 
population’s health. Integration of the EHR with WVEDSS-NBS affords health 
professionals instant access to the most recent health data and thus allows local health 
departments to effect social change. Positive social change begins with reducing 
morbidity and mortality of infectious diseases within the population and this study 
identified issues related to timeliness and the completeness of intake forms. Colbert and 
Harrison (2011) stated that to accomplish these objectives and to understand the complex 
matrix of health disparities, more complete epidemiological and surveillance data must be 
acquired. An evaluation of surveillance system data was done on West Virginia to 
identify the incidence of Category II infectious diseases and to assess the effectiveness of 
the state health department by examining, comparing, and evaluating the old WVEDSS 
and the newly developed WVEDSS-NBS for the system attributes of timeliness and 
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completeness. I used the diffusion of innovation theory to examine the environment in 
which the surveillance systems operated in order to identify areas for improvement and 
sustain social change.  
Significance 
Health practitioners in West Virginia could use the results of this research to 
improve the time from reporting of the infectious disease to recording them in the 
database. With accurate and timely reporting, public health officials have the necessary 
data to plan, organize, and implement public health interventions and policies to prevent 
and control infectious disease outbreaks in West Virginia. 
1. Improve the timeliness of reporting the Category II infectious diseases in West 
Virginia by establishing evidence-based evaluation criteria to identify differences 
in mean reporting time. 
2. Identify sources of reporting delay from the 24-hour standard within Category II 
infectious diseases in West Virginia. 
3. Improve the completeness of required fields for both data sets of Category II 
infectious diseases of the West Virginia by examining identifier, dob, gender, 
state, county, identifier for reporting facility, program area, jurisdiction, date 
received by public health, specimen source, date specimen collected, resulted test, 
organism, and add test result button. 
Summary and Transition  
The current WVEDSS-NBS was active as of March 2012 and further 
implementation of the system continued throughout 2014. Data from the old system, 
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WVEDSS, was not used in the current system because only new data was uploaded. The 
goal of the current WVEDSS-NBS is to implement and incorporate infectious disease 
data across multiple states surrounding West Virginia and integrate the IDSS with the 
electronic health record (EHR). The goal of this study was to compare the system 
attributes of timeliness and completeness of the previous WVEDSS to the current 
WVEDSS-NBS to ensure the accuracy of surveillance system data. 
Chapter 2 will connect the variables of the two data sets to the system attributes of 
timeliness and completeness.  This study specifically focused on the valuation of 
reporting the Category II infectious diseases (Table 1) before and after the Web-based 
server was employed in March 2012. Key variables and their relation to the system 
attributes were discussed to further the analysis of the two data sets. 
Chapter 3 will discuss the research method, a quasi-experimental interrupted 
time-series design comparing two data sets before and after a technological intervention. 
The evaluation of data is an integral part of surveillance systems access and usage.   
Chapter 4 will discuss the time frame for data collection, discrepancies in data collection 
from the Chapter 3 plan, baseline descriptive and demographic characteristics of the 
sample, challenges to implementation as described in Chapter 3, statistical assumptions, 
and results.   Chapter 5 will discuss the interpretations, limitations, recommendations, and 
implications of these findings. 
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Chapter 2: Literature Review 
Introduction  
Despite technological advances in pubic health informatics, the evaluation of 
infectious disease surveillance systems data remains incomplete.. Sickbert-Bennett, 
Weber, Poole, MacDonald, and Maillard (2011) stated that the evaluation of infectious 
disease surveillance system data is not complete and further measures need to be 
undertaken to ensure the reliability of these statistics. According to Baker, Easther, and 
Wilson (2010), potential gaps exist within surveillance system data and existing data is 
not integrated with the electronic health record.  Chriqui, O’Connor, and Chalaoupka 
(2011) agreed with Baker et al., writing that there was a need for a consistent review of 
surveillance systems, especially in regard to the development of policy and interventions. 
Baker et al. (2010) suggested the use of WHO and IHR standards to assess variances in 
surveillance system data, to identify improvements at the local level, and to examine all 
relevant surveillance system stages across an area of disease burden. Sahal, Reintjes, and 
Aro (2009) illustrated the point, writing that the main issue is in the completeness of 
reporting surveillance system data. Routine evaluations of surveillance systems are 
imperative for infectious disease detection and for ensuring that accurate feedback is 
provided to health professionals. Therefore, the purpose of this study was to identify key 
sections within the two data sets, (WVEDSS and WVEDSS-NBS), where data may be 
absent or lacking so that corrections could be made to the system. This chapter provides 
an in-depth examination of issues related to public health surveillance. 
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Literature Search Strategy 
To identify prospective, peer-reviewed articles and books, the following 
databases—PubMed and Medline—were searched for the years 2008 to the present using 
the following keywords (with Boolean operators to maximize the results): surveillance 
systems, electronic surveillance systems, infectious disease surveillance, WVEDSS, 
WVEDSS-NBS, timeliness of surveillance systems, completeness of surveillance systems, 
diffusion of innovation theory, sensitivity of surveillance systems, positive predictive 
value of surveillance systems. The CDC website was also valuable.  
While the review focused on current peer-reviewed articles, it included an 
extensive review of theories and seminal literature related to surveillance system policy 
and government interactions. The literature review was organized by themes found in the 
literature: the problem statement, the diffusion of innovation theory, the quantitative 
method for surveillance systems, system attributes of timeliness and completeness, and a 
summary. 
Theoretical Foundation: Diffusion of Innovation 
Source of the Theory 
Rogers developed the theory, diffusion of innovation, in 1995 and wrote five 
books about the theory over the next 8 years. Rogers (2003) stated that diffusion is more 
of a social progression than a mechanical issue. This paper will utilize his first book and 
his most recent work of the same title written in 2003 with updates that have occurred in 
research and innovations since his first publication. Greenhalgh et al. (2008) illustrated 
that the more complex the technology behind an innovation the greater the chances of 
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failure of the innovation. Rogers (2003) emphasized that the diffusion of innovation 
describes social change as an essential aspect of human development. According to 
Greenhalgh et al. (2008), the aspect of diffusion of innovation that deals with the 
integration of the social and technological aspects is defined as the socio-technical aspect 
of change (p. 9). Healthcare surveillance systems are multifaceted structures that embody 
more than the social and technological aspects of surveillance systems. They incorporate 
outbreak information, social, technological, managerial, privacy, and security aspects and 
all of these must be processed, adapted, and mastered by individuals and groups within 
the system.  
Major Theoretical Propositions 
 A technological innovation requires more information to be exchanged within the 
system and if done correctly reduces uncertainty among the stakeholders embracing the 
innovation. According to Rogers (2003) diffusion of innovation is the progression of 
communication exchange throughout a social system that initiates social change within 
the system. The organization undergoes alterations in the configuration and purpose of 
their social system through the integration of new philosophies and technologies by 
change agents. Rogers stated, “the main elements of the diffusion of innovation theory 
are innovation, communication, time, and the social system” (p. 861). These elements can 
be identified in all studies and programs revolving around the theory. 
Technology is a blueprint for implementing a change to reduce the uncertainty 
about the advantages and disadvantages of achieving a certain outcome. Two basic 
aspects of technology include the hardware (the tool) and the software used as the 
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knowledge center for the tool. Rogers (2003) stated that the decision making process uses 
information gathering and information reasoning as another means to overcome user 
doubts. According to Rogers (2003) researchers need to evaluate all the existing 
technologies within a surveillance system as a technology cluster because they are 
intimately related. He defined a technology cluster as one or more elements of technology 
that are symbiotic and diffuse at the same time in a system (p. 383). Past research focused 
on each new technological development as an isolated innovation. Rogers (2003) 
identified “rate of adoption (relative advantage and compatibility), complexity, 
trialability, and observability as the perceived attributes of innovations” (p. 1346). 
Greenhalgh et al. (2004) emphasized these attributes in their work and they can be 
identified as diffusion, dissemination, implementation, and sustainability (p. 582). These 
attributes have been identified through past research as the most important aspects in 
explaining adoption rate. 
Literature and Research-Based Analysis 
Prior research on the diffusion of innovation theory used specific criteria to 
examine the overall evidence supporting their conclusions and discussed thirteen research 
areas supporting the theory in health service organizations. Greenhalgh et al. (2004) 
traced the chronological growth of the perceptions, the model, and the approaches in 
diffusion of innovation by examining the literature and evaluating experts in different 
fields, and quantifying this data as narrative. They designed an information-mining tool 
to abstract the key aspects of the theory to compare in their narrative using the World 
Health Organization Health Evidence Network (WHO-HEN) criteria. Earlier research on 
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diffusion of innovation theory was classified under four categories:  rural sociology, 
medical sociology, communications studies, and marketing studies.  
Opinion leaders and change agents influence interventions and communication 
within the organization or system. Rogers (2003) developed the area of rural sociology 
and he defined innovations as new concepts to farmers and defined diffusion as the 
spread of individual ideas mostly by imitation (p. 591). Rogers (2003) illustrated the 
importance of social networks specifically how individuals became adopters and how 
they make the decision to adopt or reject a technology. The medical sociology model 
followed Rogers’s model but applied to doctors, particularly their behaviors when 
prescribing new antibiotics. These early studies set a precedent, as their focus was to 
define individuals who used social networks as cultured and sophisticated consumers 
marking them as the first to embrace new inventions.   
Rogers (1995) developed his fundamental concept of diffusion of innovations 
through the rural sociological approach using communication studies that focused on 
innovations as ‘news’ or information that was spread through the news network of 
television, newspapers, or by individuals. Rogers and Kincaid (1981) focused their 
communication research in this area focusing on how fast the message was transmitted, 
where the message was transmitted, and how the changing critical variables influenced 
diffusion. The marketing category studied innovations as if they were products and 
developed mathematical models to forecast adoption behavior (Bass, 1969; Boehner & 
Gold, 2012). Potvin, Haddad, and Frohlich (2001) identified the qualities and demands of 
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innovations, the personalities and behaviors of adopters, and the effect of the magnitude 
of media campaigns on adopter’s decisions.  
As a result of the limitations identified in the conceptual models several new 
research areas were created including: development studies, health promotion, evidence-
based medicine, and several areas in the organization and management literature. These 
earlier studies had many faulty theoretical suppositions: the individual was all that 
mattered, that accepting the new idea was the only decision; adoption can be predicted by 
examining the character of the adopters, and that diffusion research is universal 
(Greenhalgh et al., 2004). Studies found in the organizational management literature 
include research done on structural climate and culture (Damanpour, 1991, 1992, 1996); 
studies conducted on the interaction between groups (Abrahamson, 1991; Abrahamson & 
Fairchild, 1999); information based approaches to innovations in organizations (Nonaka 
& Takeuchi, 1995; Zahra & George, 2002); and organizational psychology (UK 
Department of Health, 2001).  
The research focusing on innovation covered the structural climate and culture 
intertwined with the conventional transformation organization literature. Studies focusing 
on organizational process, context, and culture dealt with three main areas of research:  
acceptance, integration, and predictable nature of an innovation (Greenhalgh et al., 2004). 
This area of research used qualitative methods, mainly ethnographic, focusing on the 
human aspect including the overall social environment of the organization emphasizing 
culture, power, leadership, and risk taking attitudes (Greenhalgh et al., 2004). Inter-
organizational studies dealt with the organization innovativeness compared to other 
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organizations on concepts that were essential to forming a social network. Studies that 
illustrated the connections between organizations focused on networking as a distinct 
form of communication within the organizations. The last area of research covered 
related to this study was organizational psychology where leadership skills such as 
pioneering, evaluation, and working effectively with employees contributed to the 
adoption of the innovation.  
Rationale for the Diffusion of Innovation Theory 
The definition and measurement of the diffusion of innovation theory provided a 
framework for the review of the literature in a systematic and methodic fashion. 
Greenhalgh et al. (2004) performed a meta-analysis of the literature using a new 
technique to answer the following question, how can we spread and sustain innovations 
in health service delivery and organization (p. 583)? Greenhalgh et al. (2004) defined 
innovation in health care as an innovative set of actions, customs, and operations that 
focus on perfecting health outcomes, managerial competence, and budgeting efficiency 
through proper planning and synchronized activities. Bunduchi, Weisshaar, and Smart 
(2011) stated that the major portion of costs occur in the early stages of a technological 
innovation with development, capital, ethical, and implementation costs prevailing. 
Greenhalgh et al. (2008) stated that identifying important aspects of the direction, vision, 
relationships, and the team in implementing a complex technological innovation begins 
with defining the theory of diffusion in innovation. Bunduchi et al. (2011) agreed that the 
technological aspect of the innovation is a significant factor and influences the outcomes 
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of the entire innovation. Integrating the technological aspect of the surveillance system 
into the daily routine of the organization is essential to its success. 
Diffusion of innovation theory establishes a predefined framework for the 
researcher to build on as the innovation is integrated into the organization. The purpose 
was to illustrate the diffusion of innovation theory so that later innovations can be done 
more efficiently through the understanding and the development of diffusion and 
dissemination. In Bauman et al. (2006) stated that the main focus was to define 
dissemination and to reinforce evidence-based practices in public health.  Dissemination 
was defined as describing the communication method utilized along certain paths by 
varying means in order to reach targeted stakeholders (Bauman et al., 2006). Greenhalgh 
et al. (2004) described diffusion as a passive process and dissemination as the active 
integration of the innovation into the organization. Diffusion occurs through personal 
encounters and is more informal and unstructured where dissemination is a formal 
planned implementation process that has a predetermined structure and uses social 
networks to create awareness and spread a message.  
The process of diffusion is first identified as an informal planning process that is 
followed by a formal structured procedure driven by social networking within the 
organization. Formal dissemination programs are accountable for understanding the 
varying viewpoints of adopters, weighing the positive and negatives, identifying 
subdivisions of the whole, categorizing their characteristics, clearly constructing a 
mission, using the appropriate communication networks; and auditing and appraising 
objectives and targets (Greenhalgh et al., 2004).  Researchers contesting the paradigms of 
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diffusion research have illustrated that those new technologies previously integrated 
using only simple diffusion should have gone through a more formal dissemination 
process (Greenhalgh et al., 2004). For instance, Rogers (2003) suggested using the 
technology cluster model for technological innovations that include more than one 
technology within the system. In this way the stakeholders consider all aspects of the 
innovation and a coordinated strategy is created for implementation. 
How the Diffusion of Innovation Theory Relates to the Present Study 
Public health researchers and professionals have campaigned for greater 
coordination in traditional public health surveillance actions pursuits.  According to 
Fedorowicz and Gogan (2010) several surveillance systems have been used to track 
infectious diseases using different data collection methods and procedures leading to an 
abundance of irreconcilable databases and applications. The uniformity of the theory 
developed by Rogers (2003) is needed to examine this technological cluster as a whole, 
as the innovation is implemented within local and national networks (Fedorowicz et al., 
2010). The theory has been utilized by Dearing (2009) to potentiate the spread of 
evidence-based practice to invoke social change. Bauman et al. (2006) stated that to 
create a solid foundation for dissemination efforts more research on diffusion in 
healthcare and public health is needed. A standard needs to be established for evaluating 
data and communicating it to stakeholders in the system. 
Public health officials need to establish methods to follow to integrate data and 
results obtained from surveillance systems to the other stakeholders in the system. 
Bauman et al. (2006) provided further evidence for diffusion and adaption efforts to be 
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focused at the local level. Green, Ottoson, Garcia, and Hiatt (2009) clearly stated that the 
research is not reaching public health decision makers and healthcare professionals. 
Greenhalgh et al. (2008) explored the launch of a shared electronic patient record (SCR) 
in England and the implementation and diffusion of the SCR within the entire healthcare 
system. They emphasized using the diffusion of innovation theory because the SCR and 
other technologies are not simple innovations their very nature is complex and the 
implementation of such technological clusters involves developing communication 
networks and time management strategies among users within the entire social system.  
The Institute of Medicine (IOM, 2010) recommended updates and changes for 
overhauling the National Center for Health Statistics (NCHS). The IOM stated that 
improving data collection and measurement, establishing a set of health indicators, and 
transforming the healthcare system would have a tremendous effect on the health of local 
populations. A superior method of collaboration is needed between innovation, public 
health, and medical care (Rust, Satcher, Fryer, Levine, & Blumenthal, 2010). The 
Affordable Care Act of 2010 (IOM, 2010) was established to alter the existing heath care 
system but innovations in public health, social, and environmental factors will need to be 
improved as well. Reijn, Swann, Kretzschmar, and Steenbergen (2011) found that each 
infectious disease has its own particular characteristics that must be examined. This data 
must then be compared for every stage in the surveillance process in order to uncover 
errors and interruptions within the system so that corrections can be made. 
Adoption of the innovation. The interconnectedness of the innovation, the initial 
adopters, and the rate at which the innovation is adopted are essential to adoption.  
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Greenhalgh et al. (2004) stated that the standard of diffusion is to be used as a memory 
aid for implementing complex innovations in diverse situations among numerous 
interactions. The empirical findings associated loosely with their model include the 
innovation, adoption by individuals, assimilation by the system, and diffusion and 
dissemination. Greenhalgh et al. (2004) stated that these factors themselves are not 
enough for the innovation to be adopted. Rogers (2003) compares adoption as a process 
versus adopter categories. People are not submissive when it comes to the adoption of 
innovations they engage and interact on all levels through conversations, feelings, and 
evaluations.  
The adopter is a principle player and team member in the adoption and innovation 
process interacting with other adopters and other teams. The four aspects of adopters 
from Greenhalgh et al. (2004) and Rogers (1995) include: personal perceptions, 
perceptions related to the technology, what the innovation means to them, and their 
adoption decision process. According to Greenhalgh et al. (2004) prior research done on 
the diffusion of innovations has mainly been based on specific, modest, and commodity-
based innovations where diffusion occurred from the impressions made by innovators in 
the field. One must not be misled by this literature and over simplify the diffusion process 
for complex technological based innovations. The successful innovator will understand 
that the distribution of adoption in the target market needs to be determined by 
observation and experiment (Rogers, 2003, p. 560). At this level, adoption is referred to 
as team assimilation to develop structures within organizations to incorporate the 
innovation.  
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 Rejection of the innovation.  Complex innovations in service organizations are 
process-based innovations and assimilations by teams, departments, and organizations 
that require changes in the essence of the working environment. Greenhalgh et al. (2004) 
compared the characteristics of developing simple innovations to complex innovations 
and described the processes involved in each method. Most of the research on 
innovations has focused on individual or simple innovations, which are developed 
through simple imitation (Rogers, 1995). In order to accomplish such a multifaceted 
mission, a formal decision making process must be formulated, evaluation phases must 
be established, and implementation must be planned, and effort sustained throughout the 
process.  
 All elements and procedures of initiating the innovation must be incorporated into 
the planning stage. Gladwin, Dixon, and Wilson (2002) stated that it is essential to 
include all information in the plan for an innovation whether simple or complex. 
Omitting steps or procedures because they are common sense can be a serious error and 
lead to rejection of the innovation. Gladwin et al. stated that implications for technology 
innovations, such as a upgrading a surveillance system from paper to electronic, are 
basically changes in the organizational structure and should be reviewed and 
implemented in this fashion. All components and elements that need to be changed or 
motivated must be included to ensure compliance and integration of the innovation.  
Implementing the innovation.  The organization’s willingness to accept the 
innovation comprises their apprehension for transformation, the ability of the innovation 
to incorporate into the existing scheme, and evaluation of the consequences of the 
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innovation. Greenhalgh et al. (2004) stated that innovation includes system antecedents 
and the systems willingness for the innovation. System antecedents are composed of the 
structural components, absorptive capacity for new information, and the organizations 
receptive ability for transformation. Greenhalgh et al. (2004) stated that operational and 
socializing components of the organization affect the probability that the innovation will 
be integrated into the organization. Provisions and promotions, devoted periods and 
supplies, and the competence to appraise the innovation are the key components of 
evaluating the consequences of the innovation.  
The literature supports analyzing the system precursors as an aggregate because 
they are multifarious, collaborative, and changeable.  According to Greenhalgh et al.  
(2004) a significant aspect of system integration identified by the literature is that a 
system’s preliminary structural dimensions, absorptive capacity, and receptiveness should 
be examined as a whole and not dissected into parts. With that in mind the individual 
precursors for the structural components, absorptive capacity, and receptiveness will be 
discussed. Organizational structural prerequisites that are sizeable, segregated, developed, 
and focused increase compliance with integration.  
Dopson, Fitzgerald, Ferlie, Gabbay, & Locock (2002) stated a significant aspect 
from the healthcare literature that was mentioned extensively was the value of the 
function of investigative evidence in the application of technologies (p.607).  Greenhalgh, 
et al. (2004) identified allocation of “slack resources” (p. 604) as an essential component 
of the structural precursors, which make up only 15% of the difference between 
organizations in the literature. Absorptive capacity precursors include the organization’s 
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proficiencies and talent base, established associated technologies, a knowledgeable and 
understanding culture, and upbeat governance dedicated to establishing communication 
networks. This evidence must be digested by the existing healthcare culture, established 
within their communication and social networks, and incorporated into their daily 
working environment.  
An organization may be prepared for innovation overall but still unequipped for a 
specific innovation especially a technologically based innovation. As the organization 
prepares for the innovation they acquire a state of system eloquence from which they 
accept or reject the innovation (Rogers, 1995). A prospective innovation that is 
successfully embraced into the organization will have the following attributes:  
apprehension for transformation, the ability of the innovation to incorporate into the 
existing scheme, and evaluation of the consequences of the innovation. The organization 
must be prepared at all respective levels in order for the innovation to be successfully 
incorporated and maintained. 
Process. The organization must respect the difference between the research and 
the application of the finding in the real world. The diffusion of innovation process 
includes “innovation development and testing, innovation dissemination, its adoption by 
a population, implementation into that population, and maintenance or sustainability of 
the innovation” (Bauman et al., 2006, p. 58). The article by Bauman et al. (2006) 
described the fundamentals for the propagation of any public health issue. Bauman et al. 
(2006) illustrated the need for identification of key policymakers, as an essential step 
throughout the process by meeting their information needs first to cement cooperation 
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throughout the process.  This begins the process of developing engaging partnerships that 
will help implement the innovation across disciplines and boundaries. The dissemination 
process is optimized when role models and leaders can be established and encouraged to 
see the project through to smooth operation.  
How Research Questions Relate to the Theory 
 This process works much better when those who will utilize the system have apart 
in the initial plan to implement. In order to establish a more organized assessment and 
evaluation to guide public health practitioners in their transition from paper based 
surveillance systems to more elaborate electronic infectious disease surveillance systems 
improvements must occur at the micro, meso, and macro level. Electronic disease 
surveillance systems are complex innovations that must be accepted, adopted, and 
integrated into the daily workload of all participants in the organization. Greenhalgh, et 
al. (2008) stated that at the micro level these complex innovations include the basic 
structure of the technology and current surveillance system, the outlook and 
apprehensions of the people involved, and the current social environment. The 
organizations past experiences with innovation, their willingness to participate in the 
innovation, and the current working components of the innovation compose the meso 
level. The CDC, NIH, and APHA and other governing bodies make up the macro level of 
the organizational structure, which includes the utilitarian and sociopolitical forces 
affecting the innovation.  
To address innovation in the surveillance system at the micro level several 
essential components of WVEDSS-NBS structure will be examined and evaluated.  
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According to the literature this data should be used to establish baselines to assess 
WVEDSS-NBS’s timeliness and completeness. Therefore, the current WVEDSS-NBS  
will be evaluated on its timeliness and completeness by comparing it to the previous 
WVEDSS. The first step is to calculate, review, and compare the infectious disease 
surveillance systems timeliness or the mean reporting time of infectious diseases under 
Category II of the West Virginia reportable infectious diseases of the previous WVEDSS 
to the current WVEDSS-NBS.  
Public health surveillance goes beyond the mere gathering, analysis, and 
explanation of data for public health practices it must report this information to the 
correct individuals in a time frame that allows them to take action if needed.  Fedorowicz 
and Gogan (2010) stated that conventional surveillance systems were designed to validate 
a particular disease involved in an outbreak, stress precision and completeness while 
ignoring the value of timeliness. Jajosky and Groseclose (2004) stated that timeliness is a 
quantitative indicator of the surveillance systems reliability and validity and is used to 
determine any time delays between operational phases. The calculation of timeliness for 
this study includes how the data is to be used, the communicability of disease, and the 
nature of the condition under surveillance. The second focus is on infectious disease 
reporting completeness of intake forms from the previous WVEDSS and the current 
WVEDSS-NBS. Doyle et al. stated in their study on notifiable infectious disease cases 
reported electronically to the local health department that using the electronic system 
resulted in a “2.3 fold increase in case reports” (2002, p. 866).   
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Summary of Diffusion of Innovation Theory  
From the first thoughts of Rogers in 1995, the diffusion of innovation theory has 
developed into addressing innovation in surveillance systems in 2014. A socio-
technological innovation within infectious disease surveillance systems requires a change 
of the social system or culture where the technology will be applied. The diffusion of 
innovation theory represents a foundational and measurable framework to guide the 
researcher on implementing innovative electronic surveillance systems around the world. 
Public health officials can use the research on the theory to integrate and understand the 
vast amount of electronic data obtained from electronic surveillance systems. Adopters of 
an innovation go through a process of adoption in which they either accept or reject the 
innovation. Adoption and subsequent implementation of the innovation require extensive 
planning, stakeholder involvement, and dissemination of the innovation across the 
organization. 
Literature Related to Timeliness and Completeness  
 This study focused on improving the assessment of infectious disease data 
retrieved from surveillance systems. In order to improve surveillance system evaluations 
this study identified areas within the WVEDSS-NBS where more complete epidemiology 
and surveillance system data may be missing or where improvements can be made to the 
system. The WVEDSS-NBS, which is being integrated with EHR, will be compared to 
the old WVEDSS and evaluated on system attributes of timeliness and completeness. 
Since the WVEDSS-NBS is now linked to NEDSS, the national system, and therefore the 
WHO, the international system, they are obligated to follow the IHR (2005). The WHO 
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(2008) stated that the IHR (2005) is a binding international law that went into effect on 
June 15, 2007 and it governs the criteria for reporting epidemiological data to the WHO, 
the WHO’s response, and requires the strengthening of member countries surveillance 
systems and response to public health risks.  
Evaluation of Epidemiology Surveillance and Response   
 Several countries have performed evaluations of epidemiology surveillance 
efforts. The components discussed will focus on methods for epidemiology surveillance 
and response, public health laboratory services, and the public health educational 
infrastructure. Nsubuga et al. (2010) evaluated four countries in Africa to recognize 
accomplishments and miscalculations using the Integrated Disease Surveillance and 
Response (IDSR) strategy.  The Africa Regional Office (AFRO) and the WHO developed 
the IDSR in 1998. This knowledge was used to build a guide to address the IDSR key 
components for evaluating integrated surveillance systems. Taboy, Chapman, Albetkova, 
Kennedy, and Rayfield (2010) investigated the integration of surveillance using the IHR 
(2005) to create a set of tools to address the challenges of the action theme to create a 
sustainable world health network for international collaboration. Takian, Petrakaki, 
Cornford, Sheikh, Barber, and NHS CRS Team (2012) assessed England’s 
implementation of a national EHR because all WHO member States and partners are 
undertaking these challenges. Case-by-case evaluations were used for comparison of 
system attributes between surveillance systems and to verify compliance with IHR 
recommendations. 
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The evaluation and comparison of case studies allowed the researcher to pinpoint 
unique aspects of the surveillance system to begin a discerning discussion about 
collective themes and unique encounters. According to Takian et al., and National Health 
Service Care Records Service (NHS CRS) Team (2012) integrated case study evaluations 
can address multiple levels of the surveillance system and identify the social, technical, 
and cultural environments. Takian et al. used a case-study design and interpretive 
approach to evaluate the implementation of England’s NHS CRS over a 30-month period 
from September 2008 to March 2011. The investigation of case studies is critical in 
establishing the sensitivity of the surveillance system (Watkins, Martin, Kelly, Madin, & 
Watson (2009).  Amirfar, Taverna, Anane, and Singer (2011) described the creation of 
quantitative quality of life measures to be integrated with a new EHR, the clinical 
decision support system, for New York Cities’ outpatient population. Amirfar et al. 
analyzed the creation of the CDSS as they went through the planning, developing, and 
implementing stages to improve population health.  
Amirfar et al. (2011) took advantage of existing innovations in technology and 
EHR to improve the quality of patient care in New York City using established 
quantitative data: 10 TCNY measures. Many researchers (Wamala et al., 2010; Nsusbuga 
et al., 2010; Takian et al., 2012; & Taboy et al., 2010) have approached the problem 
(incomplete evaluation of surveillance systems and data quality) by evaluating their 
systems using the IHR (2005) and IDSR tools developed by the World Health 
Organization. Wamala et al. (2010) stated that their evaluation of Uganda for compliance 
with the IHR (2005) included five core capacities: infectious, chemical, zoonosis, food-
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safety, and radio-nuclear. Using the technical guidelines outlined by the IDSR they 
identified strengths and weaknesses in WHO’s approach to improving the evaluation, 
implementation, and collection of data within surveillance systems. The major strength of 
their study was it identified gaps in applying the IHR (2005) and uncovered worldwide 
security issues. Africa needs to address these issues at the national level and the WHO at 
the international level because no established legal framework is in place to support and 
enable the required procedures to comply with the IHR (2005). Applying the strategies 
outlined in the IDSR allowed them to reexamine their existing goals, objectives, and 
interventions in an organized and structured way.  
Reviewing these constructs provided them with ammunition to develop new 
objectives in line with WHO's IHR (2005). Nsubuga et al. (2010) also focused on the 
implementation of the IDSR in Africa but broadened their research to include four 
countries. One major weakness of the IDSR, their tool for evaluation, is that it is still 
evolving and the data they obtained was mostly qualitative. Taboy et al. (2010) used the 
Integrated Disease Investigations and Surveillance (IDIS) tools developed by the 
Laboratory Systems Branch of the CDC and the U.S. Defense Threat Reduction 
Agency’s Cooperative Biological Engagement Program (CBEP) to focus on a systems 
approach for outlining effective implementation approaches.  
The IDIS tools enabled evaluators to combine their ideas, thoughts, and critiques 
of the system to identify proficiencies and encourage dialogue on sustainable local, state, 
national, and international communication networks. Lack of sufficient technology and 
methods to interlink the CDC and CBEP may have had detrimental effects in other areas 
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of the public health system. Takian et al., and NHS CRS Team (2012) stated that their 
longitudinal approach to the social and technological assessment of England’s NHS CRS 
occurred simultaneously with the implementation process. The ability to change focus 
from end point evaluation of surveillance data to analyzing changes as they take place 
within the system is one of their major strengths. Thus, it was also a weakness because it 
could show only a limited part of implementation, the predicted research plans were 
inaccurate, and the length of the study was short. 
Attributes of Surveillance Systems 
         To accomplish a thorough review of the surveillance system the diffusion of 
innovation theory was utilized to connect the system attributes examined. According to 
Watkins et al. (2009) system attributes for measuring the sensitivity of a surveillance 
system should include timeliness, completeness, and the geographic and demographic 
data of the population. Williams, Vally, Fielding, and Cowie (2011) followed the 
recommendations of the CDC to establish disease registries to improve the completeness 
of intake forms fields and allow the user to incorporate additional public health 
information. The authors also identified under reporting of communicable disease as a 
cause for concern regarding the completeness of data. The IDIS tools developed by the 
CDC and CBEP developed pathogen specific templates that were used to compare 
completeness of intake forms from the old system to the new system (Taboy et al., 2010). 
Nsubuga et al. (2010) stated that the integration of existing surveillance systems with the 
electronic health record (EHR) increased the efficiency of the system. In order to ensure 
timeliness and completeness across the whole health system an all-inclusive approach is 
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required because of the complex nature and multiple interrelated factors surrounding 
technological innovations.  
Timeliness 
In this study, the timeliness or the reporting time of infectious diseases under 
Category II of the West Virginia reportable infectious diseases of the previous WVEDSS 
was compared to the current WVEDSS-NBS. Timeliness was evaluated by compliance 
with Category II guidelines that notifiable infectious diseases are reported within the 
recommended time period, average time lags, and the cumulative time lag between each 
step in the surveillance process (Yoo et al., 2009). The WHO (2008) outlined guidelines 
on timeliness that are assessed by measuring the time taken for each step from disease 
onset to International reporting. Jajosky and Groseclose (2004) stated that timeliness is a 
quantitative indicator of the surveillance systems reliability and validity and is used to 
determine any time delays between operational phases. Timeliness is a key element and 
should be used as a consistent evaluation and measurement tool of surveillance systems 
(Yoo et al., 2009). Perhaps the major error that has been made in the past in the 
measuring of timeliness is that it has been assessed as a single process.  
 Definition.  In the literature timeliness has been measured as the speed between 
steps in the surveillance process, the time between disease onset and reporting to local, 
state, national, and international agencies, and as the time between proxy values 
established for disease onset and disease reporting. According to Reijn et al. (2011) no 
standard quantitative measure for timeliness in surveillance systems has been established. 
I will evaluate timeliness on two factors: mean reporting time and within 24 hours of 
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disease onset, the standard for Category II infectious diseases. Yoo et al. (2009) stated 
that timely reporting is effected most by the interval from disease inception to diagnosis. 
Yoo et al. (2009) stated that previous research has indicated that the surveillance steps of 
infectious disease reporting vary from system to system and from one infectious disease 
to another. Category II infectious diseases of WV will be considered reliable if they are 
reported within 24 hours to the LHD.  
 The most important aspect in evaluating the timeliness of a surveillance system is 
to establish a standard definition and establish a quantifiable factor to measure it. 
Timeliness was defined in terms of mean reporting time and the 24-hour standard. 
Jajosky and Groseclose (2004) collected data on the National Notifiable Disease 
Surveillance System (NNDSS) and suggested using the earliest known date of disease 
onset as the starting point for the measurement of timeliness, varying by disease. The 
comparison of timeliness across surveillance systems and from paper to a Web-based 
server illustrated key factors causing delays in the timely reporting of infectious diseases. 
Results of Previous Studies.  Reijn et al. (2011) stated that study methods for 
timeliness varied from comparing paper to electronic systems and timeliness measures 
across boundaries. In their evaluation of the Dutch Municipal Health Services (MHS) on 
timeliness they identified two key intervals for timeliness as the time period between the 
onset of symptoms and MHS notification, and between laboratory diagnosis and MHS 
notification. They used distribution of means as their statistical test to evaluate timeliness. 
Vogt, Spittle, Cronquist, and Patnaik (2006) illustrated how a LHD could evaluate the 
Colorado Electronic Disease Reporting System (CEDRS) for timeliness and 
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completeness. Timeliness was defined as the time period between “specimen collection 
date” and “report date” for each patient and they compared them through distribution of 
mean. Records were said to be complete if all required fields were filled. Most fields 
were found to be complete except for the “diagnosis date” field but a new field was 
created “test result date” to substitute for the date of diagnosis. Their results prompted 
training of disease investigators to fill out intake forms completely with the hope that 
future evaluations will yield improved timeliness and more complete data. I measured 
timeliness from the date of diagnosis to the reporting date to the state health department 
and evaluated each disease on the distribution from the mean. 
In order to reduce the spread of infectious diseases continual efforts need to be 
applied to improve the timeliness of surveillance systems. Reijn et al. (2011) stated that 
infectious disease surveillance systems (IDSS) should be regularly evaluated for each 
step in the system for each disease within the system. Reijn et al. found that the 
proportion of infectious diseases reported to the LHD varied by disease, 0.4% for 
shigellosis and 90.3% for HAV infection. They compared the median incubation period 
of each infectious disease to the median time it took to report the disease to the health 
department. They used incubation period as their standard measure and reliability marker. 
Some of the most common reasons for delayed reporting are patient’s recognition of 
symptoms, communication issues, missing data, incorrect data, disease specific 
incubation periods, and laboratory-related delays. Reijn et al. (2011) illustrated that 
electronic laboratory reporting (ELR) has improved the timeliness in some nations and 
concluded that an international standardization method for measuring timeliness be 
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supported. The WVEDSS-NBS has not implemented ELR within its system however a 
delay in diagnosis was found to be a common disruption of timeliness in the next study 
even though they used data from an ELR system.  
The evaluation of data from surveillance systems being assessed for timeliness 
varies because each study examines different diseases and measures of timeliness. Yoo et 
al. (2009) evaluated over 40,000 infectious disease records from an electronic system that 
collected data in 2000. They found that the greatest time delay stemmed from the delay in 
diagnosis from the clinical side and from the excess time spent on lengthy laboratory 
tests. They found that the total time from disease onset to reporting to the local health 
department ranged from six to twenty days and varied from one disease to another. 
Nicolay et al. (2010) evaluated the timeliness of different species of Salmonella and 
found that timeliness varied even among the different species. They found that 
notification from physicians was faster than laboratory reporting the opposite effect of 
what was uncovered by Yoo et al. (2009).   
However, most studies found that electronic reporting resulted in an improvement 
in all system attributes especially timeliness. Effler, Ching-Lee, Bogard, Ieong, 
Nekomoto, and Jernigan (1999) compared an electronic reporting system to the previous 
conventional system and found a 2.3 fold increase in infectious disease reporting with the 
new system. The CDC (2005) stated that in New Jersey, which has a Web-based server 
like WVEDSS-NBS implemented in 2001, the number of cases reported from 2002 to 
2004 doubled and that the average days for case reporting dropped from 28 days in 2002 
to 3-4 days in 2004. In Massachusetts the implementation of several interventions, 
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including Web-based infectious disease surveillance system, improved timeliness by 
decreasing median reporting times from 454 days in 2004 to 26 days in 2008. Lazarus, et 
al.  (2009) stated that despite all of the improvements made in surveillance systems 
across the country some important internal mechanisms still depend on people. Even 
though we have come a long way and improved several qualitative and quantitative 
aspects of infectious disease reporting training and integrating primary stakeholders 
within the system remains essential. 
  Past Problems.  Electronic reporting, electronic health records, and electronic 
laboratory reporting have the potential to improve all system attributes. Wurtz and 
Cameron (2005) illustrated that despite these obvious improvements in infectious disease 
surveillance the physician must still do their part in submitting a comprehensive and 
well-timed case report. Lazarus et al. (2009) quantified that electronic laboratory 
reporting is held in high regard by experts in the field but without integration with the 
electronic health record the ELR is deficient in essential information for case detection 
and the condition of the disease. Even though most states have adapted to national 
guidelines by using the NEDSS equivalent software to upgrade their paper based systems 
to electronic or Web-based servers many problems still exist in establishing standards for 
information exchange. Nicolay et al. (2010) stated that research has proven that 
implementation of electronic reporting will decrease timeliness and increase the 
completeness of surveillance statistics.  
The CDC (2005) stated that establishing secure channels and standards for the 
exchange of infectious disease, ELR, and EHR data between public health officials and 
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clinicians remains a challenge. Heisey-Grove, Church, Haney, and Demaria (2011) 
suggested that direct integration of data from the EHR would decrease the timeliness of 
reporting infectious disease outbreaks. As the interface between clinicians and public 
health officials improve the data becomes more streamlined and universal. In the past 
health data was faxed, mailed, or emailed to the local or regional epidemiologist to be 
entered into the state system. The epidemiologist entered this data into the system 
sometimes weeks after the information had been received or the notifiable condition had 
transpired. The CDC (2005) reported that many (10-85%) of these cases never made it to 
the national level and previously states used over 100 different systems to send reports to 
the CDC. A review of the literature has revealed that many definitions and standards of 
measurement for timeliness have been used in the past. Madoff, Fisman, and Kass-Hout 
(2011) concluded that incorporating the Internet into surveillance reporting would 
improve timeliness, sensitivity, and completeness of surveillance system data. I followed 
the CDC’s recommendations for assessing timeliness in order to establish a baseline for 
timeliness comparison by disease category for future research. According to the CDC 
(MMWR, 2001) improved timeliness allows for adequate and accurate development of 
policies and interventions. Computerized technology allows for the assessment of 
timeliness to be completed routinely on each step in the public health surveillance 
system.  
Timeliness of Electronic Data Systems.  Electronic disease reporting has 
become the standard by which all other reporting is to be compared. According to several 
researchers (Reijn et al., 2011; Yoo et al., 2009; Nicolay et al., 2010; Doyle et al., 2002) 
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electronic disease reporting has improved the timeliness of infectious disease outbreak 
notification.  In addition these authors and the CDC (2005) recommend that states 
integrate ELR into their existing systems to improve timeliness because laboratory tests 
are used to confirm most infectious diseases, labs are important members of the system, 
and laboratories can be used for other aspects of public health surveillance. Evaluating 
infectious diseases by integrating the above systems improves timeliness and supports 
more complete evaluations since infectious diseases must be assessed individually 
because of critical diagnostic criteria. Nicolay et al. (2010) stated that research has 
proven that implementation of electronic reporting will decrease timeliness and increase 
the completeness of surveillance statistics. Electronic data and evaluation methods at the 
local, state, national, and international level allows for more complete assessment of 
infectious diseases and their spread around the globe. 
Completeness 
Completeness was measured by the ratio of incomplete fields to complete fields 
of required data items on the WVEDSS-NBS intake form that has been filled. Lazarus et 
al. (2009) stated that completeness could be measured as the percentage of the essential 
statistics required identifying a particular infectious disease. According to Doyle et al.  
(2002) infectious disease reporting completeness identifies those notifiable cases that 
have been reported to the local health department. The completeness of intake forms is 
crucial to the proper accounting of cases of infectious disease within a population. 
Without this vital information to guide epidemiologist and other public health officials in 
the diagnosis of notifiable infectious diseases, outbreaks may be missed and epidemics 
62 
 
may occur. I evaluated completeness in this study by the ratio of incomplete fields to 
complete fields. 
Definition.  Lazarus et al. (2009) stated that the main issue with using data fields 
on intake forms to measure completeness is the agreement of what is required for each 
form. I assumed in this study that all fields are required for a particular case or that each 
data field within a section is entered correctly. I also assumed that a data field is complete 
if there is an entry for that field. 
Results of other studies.  Lazarus et al. (2009) found in their study on 
completeness that failing to report an individual case with a notifiable condition, false 
positive, was worse than reporting case that later turned out to be negative, false positive. 
The false positive case wasted valuable time but the false negative case actually 
decreased the efficacy of public health interventions. Comprehensive, itemized case 
information is needed for public health prevention programs that are usually not available 
from conventional manual forms. In a study performed by Effler et al. (1999) they found 
using capture/recapture methods that out of 21 data fields common to both electronic and 
paper intake forms, electronic forms were considerably more complete; thus identifying 
that the electronic format to be far superior to the conventional paper or manual format. 
This leads to the evaluation of the intake forms submitted electronically and the 
intake forms submitted by the conventional method. Heisey-Grove et al. (2011) stated 
that they began using the optical character recognition (OCR) form in 2004 for Hepatitis 
C and from 2005 to 2008 the amount of intake forms received increased dramatically and 
the percentage complete intake forms increased by three percent. They used the case 
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ascertainment method to analyze completeness of intake forms. Doyle et al. (2002) 
reviewed published articles in the U.S. from 1970 to 1999 that evaluated disease 
completeness quantitatively by comparing the number of forms received by comparing 
this number to the number received by another collection method. The degree of 
completeness in these studies ranged from 9% to 99% and was intensely related to the 
disease studied. According to Sickbert-Bennett et al. (2011) disease completeness varied 
not only by disease in their retrospective cohort study but also by healthcare system. 
Their results showed that disease specific completeness varied from 0% to 82% and 
completeness overall was quite low for all diseases. These results are important because 
they identify several factors essential to the evaluation of infectious disease completeness 
data.  
It is important to evaluate infectious disease completeness by each disease under a 
specific Category and to examine each reporting source independently to uncover 
reporting patterns. Jajosky and Groseclose (2004) stated that mandatory infectious 
disease reporting in the United States varies from 9–99% and that active surveillance 
completeness was much better than passive disease surveillance systems completeness. 
They also indicated that the timeliness of active and passive were relatively the same. 
This information is important because it links the system attributes of timeliness and 
completeness and emphasizes the significance of evaluating them simultaneously before 
drawing any conclusions about the nature of the system. I evaluated disease completeness 
by assessing the ratio of incomplete to complete fields on both datasets intake forms. 
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Past Problems.  Evaluating a system based on one attribute will highlight key 
aspects of the system related to that attribute only and will not address other key 
attributes of the system. The NEDSS has outlined standards for the evaluation of 
surveillance systems to improve the accuracy, completeness, and timeliness of infectious 
disease reporting in the United States. The CDC along with health departments across the 
nation is working to improve the public health infrastructure by integrating infectious 
disease surveillance systems with clinical information systems. In essence they are 
rebuilding the medical and public health infrastructure as one united system. Heisey-
Grove et al. (2011) stated that for this to take place more education is needed to inform 
the clinical professionals about the importance of submitting this data and why it is 
important to collect it. Training on electronic medical records and other electronic health 
information systems does not occur in medical school and needs to be on the job training. 
Manually submitted data from clinicians has been a source of partial, inaccurate, 
and untimely information movement in the past. Clinicians outreach programs are 
essential according to Lazarus et al. (2009) because despite considerable progress in 
electronic reporting many significant surveillance procedures still rely on practitioner’s 
manual entry and submission of data. The evidence has demonstrated that the timeliness, 
completeness, and efficiency of data have been greatly affected by data originating from 
clinicians. Comprehensive, specific infectious disease case information, which goes 
beyond the standard intake form, is needed for public health integration, policies, and 
intervention planning and implementation. 
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In the past public health infectious surveillance system data was sent to the CDC 
using multiple methods (fax, email, and paper) compiled by hundreds of different 
surveillance programs (WV DHHR, 2014). According to Jajosky and Groseclose (2004) 
the United States public health system and the CDC have created a plan to improve the 
public health infrastructure and implementation in America. The NEDSS was developed 
to help states across the country to integrate their surveillance systems (like WVEDSS in 
WV) with the national system (WVEDSS-NBS) and the electronic health record. The 
NEDSS promises to improve the timeliness and completeness of infectious disease 
surveillance information exchange. 
Previously measuring the completeness of disease reporting was a difficult task 
but necessary to correctly elucidate infectious disease incidence or to make infectious 
disease comparisons across national and international boundaries. Doyle et al. (2002) 
explained reasons from the literature for incomplete infectious disease reporting in the 
past. The reasons included safety and privacy issues, misinterpretation of the law 
regarding notifiable conditions, ignorance of required infectious disease to report, 
clueless about where and to whom to report, and inadequate punishment for not 
reporting. According to Sickbert-Bennett et al. (2011), the evaluation of the NEDSS in 
the United States is inadequate and previous studies differ on their assessment of 
reporting completeness. This variability in the measurement of reporting completeness 
makes the relationship and combination of assessment data difficult to evaluate. 
Completeness of electronic data systems.  Automated reporting may be the 
future of electronic disease surveillance systems. Effler et al. (1999) stated that laboratory 
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staffs are active participants in infectious disease reporting; electronic laboratory 
reporting (ELR) could improve the timeliness and completeness of infectious disease 
reporting. In the conventional system clinicians and other health professionals are passive 
participants in infectious disease reporting. The estimated completeness of the 
conventional system evaluated by Effler et al. (1999) was 38% (95% CI [37%-39%]) 
compared to the electronic system, which was 80% (95% CI [77%-82%]). Heisey-Grove 
et al. (2011) agreed that the conventional system was always incomplete especially in the 
area of vital risk prevention data fields. Doyle et al. (2002) stated that active surveillance 
has proven to have a more complete case record than passive surveillance. The ELR is a 
useful and timely tool in infectious disease surveillance. 
Although electronic laboratory reporting (ELR) may be timely it still lacks vital 
clinical information essential in determining and localizing infectious disease outbreaks. 
Lazarus et al. (2009) stated that ELR may be the gold standard for disease reporting but 
the clinical data found in the EHR is crucial for reporting completeness. Doyle et al. 
(2002) illustrated that the complete integration of all systems as one automated systems is 
the future of surveillance systems, ELR, and the EHR. Much like the NEDSS and the 
CDC are doing in the U.S. restructuring the clinical system and public health systems into 
one complete health system. 
Summary 
 According to Taboy et al. (2010) the International Health Regulations (IHR, 
2005) were created as a set of tools to address the challenges of the action theme to create 
a sustainable world health network for international collaboration. Additionally they were 
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established to identify standard definitions or procedures for system attributes: timeliness 
and completeness. Several studies have suggested that the quality of surveillance system 
data is unknown because the assessment protocol for surveillance has yet to be 
established. The IHR (2005) took effect in 2007 and complete implementation was 
supposed to occur by the end of 2012 in WHO member states. This study filled the gaps 
in the literature by providing the most common definition and measures for timeliness 
and providing the meaning and a standard measure of completeness. A quantitative study 
design was implemented to examine the existing measures used in WVEDSS-NBS with 
the old system WVEDSS to establish baseline data, definitions for system attributes and 
the overall effect of the integration with the EHR.  
The research method that is discussed in more depth in Chapter 3 will be a quasi-
experimental interrupted time-series design comparing two data sets before and after a 
technological intervention. The evaluation of data is an integral part of surveillance 
systems access and usage.  
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Chapter 3: Research Method 
In spite of the improvements to surveillance systems the assessment of the 
reporting of infectious disease data is imperfect and incomplete. The purpose of this 
study was to identify areas where more complete epidemiology and surveillance system 
data is missing or where improvements can be made to the system. The system attributes 
(timeliness and completeness) of WVEDSS-NBS were compared with the previous 
system, WVEDSS. All research is based on some basic principle or worldview; the post-
positivist view was used in this study. 
This chapter discusses the research design and rationale, connection of research 
design and variables to the research questions, time and resource constraints, research 
questions, methodology, threats to validity, and a summary. This study used the quasi-
experimental, interrupted time-series design, which was analyzed using quantitative 
methods. To address the goals of this study, the diffusion of innovation theory was used 
to incorporate the multifaceted components of technological innovation with archival 
infectious disease surveillance data. 
Research Design and Rationale 
Research Variables 
The key variables in this study were the cases/reports, timeliness, and 
completeness. The key independent variables were the system attributes of timeliness and 
completeness. The key dependent variables were the cases/reports of Category II 
infectious diseases. In order to accomplish these goals, the current WVEDSS-NBS was 
evaluated on its timeliness and completeness by comparing it to the previous WVEDSS.  
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Research Design and Connection to the Research Questions 
 This study used the quasi-experimental, interrupted time-series design along with 
the  diffusion of innovation theory in order to evaluate WVEDSS and to compare it to 
WVEDSS-NBS on a case-by-case basis. The case study comparison was used to identify 
factors that may contribute to disruptions within the surveillance system. According to 
Harris, McGregor, Perencevich, Furuno, Zhu, Peterson, and Finkelstein (2006) and Harris 
et al. (2004), nonrandomized, quasi-experimental designs are frequently used when 
randomized control trials are not appropirate or practical. In medical informatic studies, 
the quasi-experimental design is intended to evaluate nonrandomized interventions before 
and after their implementation; which the before and after interventions are then 
compared to nonrandomized control groups. Harris et al. (2006) and Ho, Peterson, and 
Masoudi (2008) explained that interuppted time-series designs are the strongest among 
the quasi-experimantal designs for establishing causality. In interuppted time-series 
designs, a series of observations are evaluated before an intervention (the interruption)  
then a series of observations are evaluated after the intervention.  
Time and Resource Constraints 
 The only time and resource constraints were in acquiring the data sets from the 
state epidemiologist for Category II infectious disease from the WVEDSS, the archived 
data, and the WVEDSS-NBS, live data. The regional epidemiologist and the state of 
West Virginia provided data from the current and previous version of the WVEDSS 
database. Other sources of information on infectious disease surveillance came from the 
70 
 
following websites: WHO, CDC, Ohio County Public Health Department, and West 
Virginia State Department of Health and Human Resources.  
Research Questions  
This study examined the following three research questions. 
4. Is there a difference in mean reporting time of Category II reportable 
infectious diseases between the two data systems (WVEDSS & WVEDSS-
NBS) in West Virginia?  
H01 - There is no difference in mean reporting time of Category II infectious 
diseases between WVEDSS and WVEDSS-NBS.  
Hₐ1 - There is a difference in mean reporting time of Category II infectious 
diseases between WVEDSS and WVEDSS-NBS.  
5. Is there a difference from the 24-hour standard (time delay) of the infectious 
diseases under Category II of the West Virginia reportable infectious diseases 
for both data sources? 
H02 - There is no difference from the 24-hour standard for one or both data 
sources.  
Hₐ2 - There is a difference from the 24-hour standard for one or both data 
sources.  
6. Are the required fields (Identifier, DOB, Current Sex, State, County, 
Reporting Facility Identifier, Program Area, Jurisdiction, Date Received by 
Public Health, Specimen Source, Date Specimen Collected, Resulted Test, 
Organism, Add Test Result Button) complete for both data sources? 
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H03 - There is no difference in completeness of the required fields for one or 
both data sets. 
Hₐ3 - There is a difference in completeness of the required fields for one or 
both data sets. 
Methodology 
The scope of this paper included the evaluation and comparison of the WVEDSS 
and WVEDSS-NBS to improve reporting times, prevention, and interventions for 
Category II infectious diseases in West Virginia. Category II reportable infectious 
diseases were chosen because they must be reported to the LHD within 24 hours and it 
includes any unusual or emerging infectious disease. The diffusion of innovation theory 
was used to understand the scope, objectives, and system attributes (identified as 
timeliness and completeness). This data was used to assess the effectiveness of the local 
health department’s policies and prevention strategies, intervention, and control measures 
for disease outbreaks to create more complete surveillance system data.  
Population 
 The target population was the regions of West Virginia. This census data has been 
compiled over a period of four years from 2007-2010. The total population in West 
Virginia under surveillance in 2010 according to the U.S. Census was 1,852,994 and 
estimated to be 1,855,413 for 2012. 
Sampling and Sampling Procedures 
 Sampling was non-random by convenience of data submitted for WVEDSS and 
WVEDSS-NBS for Category II infectious diseases in WV. I obtained permission for all 
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state data for Category II infectious diseases. Category II infectious diseases were chosen 
for this study because they include emerging infectious diseases and any other unusual 
conditions. According to Sahal, Reintjes, and Aro (2009), it is beneficial to study many 
different diseases within a surveillance system to get a larger representation of how the 
entire population is affected. All data reported for the above infectious diseases from 
WVEDSS (2007-2010) and WVEDSS-NBS (March, 2012- March, 2014) for Category II 
infectious diseases (Table 2) was included in the sample.  
 Power analysis to ensure appropriate sample size.  Power analysis was 
conducted to ensure that the sample size from available secondary data would meet a 
minimum level of 95%. They following parameters were included in G*Power 3.1.7 
(Faul, Erdfelder, Lang, & Buchner, 2007 and Faul, Erdfelder, Buchner, & Lang, 2009): 
Test family (Exact), Statistical test (Inequality, two independent groups (Fisher’s exact 
test), Type of power analysis (A priori: Compute required sample size), two tails, 
proportions dataset 1 (WVEDSS) = x1, proportion dataset 2 (WVEDSS-NBS) = x2, α = 
0.05, Power (1- β err problem) = 0.95, and allocation ratio (N1/N2) = 2. The proportion 
sizes (x1, x2) were determined from the West Virginia DHHR website on infectious 
disease surveillance cases from 2007-2014. The following outputs were determined: 
sample size haemophilus influenza invasive 1 = 12, group 2 = 24, total sample size = 36; 
sample size hepatitis type A acute group 1 = 417, group 2 = 834, total sample size = 
1251; sample size hepatitis type B group 1 = 495, group 2 = 990, total sample size = 
1485; sample size pertussis group 1 = 7, group 2 = 14, total sample size = 21; sample size 
rabies human group 1 = 11, group 2 = 11, total sample size = 22; sample size rubella 
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group 6= 100, and total sample size = 150. As there were thousands of cases available for 
analysis among the WVEDSS and WVEDSS-NBS datasets, there was no issue with 
obtaining minimum sample size. 
Archival Data 
 The WV State Infectious Disease Epidemiologists were contacted to receive 
permission to work with archival data within the WVEDSS (2007-2010) and WVEDSS-
NBS (March, 2012- March, 2014). Authorized users manually enter data into disease 
reporting forms (specific for each disease) on the Web-based server WVEDSS-NBS.  
Permission was obtained from the state’s IRB committee and Walden’s IRB committee 
approved a data use agreement. The state epidemiologist blinded the data and a HIPPA 
and consent form to use the data for research purposes was signed before data was 
released to the student. The data were stored on a separate hard drive after being blinded 
by state officials. 
Operationalization of Constructs 
 The WVEDSS-NBS outlined the procedures for preparing a disease report for 
notifiable infectious diseases on the West Virginia Department of Health & Human 
Resources (WVDHHR) website. They provided a quick reference guide for reporting 
infectious diseases into WVEDSS and other resources to guide users on submitting 
complete and up to date information. The epidemiologist review all reportable cases and 
investigates each case individually to confirm the infectious disease responsible. Each 
disease under Category II in West Virginia has a separate intake form that was available 
for entry online. Once the health professional entered the initial intake information into 
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WVEDSS, the epidemiologist then is able to check the information and send that 
confirmed infectious disease to the state office, which sends it to the CDC.  
Data Analysis 
All data was stored in Microsoft Excel and imported into SPSS for statistical 
analysis. The two datasets were entered into an excel document and this data was 
reviewed to address issues in reliability, credibility, validity, and practicality of 
information. I assessed the dataset’s reliability and credibility by evaluating the level of 
bias and confidence intervals, validity of collection method and practicality of the 
datasets was assessed using triangulation when possible and verified by the source’s 
dependability (The Assessment Capacities Project, 2014). According to Harris, et al.  
(2006) statistical analysis of quasi-experimental design using interrupted time-series data 
can detect variations in mean and in the slope or intercept as an effect of the intervention. 
Descriptive statistics was performed to get an understanding of the data.  
Research questions evaluated differences in mean reporting time, the 24-hour 
standard, and complete fields (DOB, gender, etc.) of the two data sets using independent 
samples t test. The t test was chosen because it was appropriate for comparison of means. 
The assumptions of the t test are bivariate independent variables, continuous dependent 
variable, each observation of the dependent variable was independent of the other 
observations of the dependent variable, and the dependent variable has a normal 
distribution, with the same variance, σ2, in each group (Weaver, 2004). If some variables 
are not normally distributed the non-parametric test, Wilcoxon Mann-Whitney was used.  
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The timeliness of Category II infectious diseases was evaluated by comparing the 
mean reporting times and the difference from the 24-hour standard. Completeness was 
measured by examining the number of fields completed on the intake forms for each form 
submitted under Category II. A field was counted as complete if there was an entry for 
that field on the intake form. I counted the number of incomplete fields per form and 
compared that to the number of required complete fields (#incomplete/#complete). Table 
3 outlined how each research question and variables were evaluated using statistics. 
Table 3 
 
Research Questions and Statistical Test 
 
Research Question Variables Statistical Test 
Is there a difference in 
mean reporting time of 
Category II reportable 
infectious diseases 
between the two data 
systems (WVEDSS & 
WVEDSS-NBS) in West 
Virginia? 
Mean reporting time = 
time reported – time of 
diagnosis 
 
t  test – comparison of 
mean difference. 
Is there a difference from 
the 24-hour standard (time 
of diagnosis to reporting 
to LHD) of the infectious 
diseases under Category II 
of the West Virginia 
reportable infectious 
diseases for both data 
sources? 
 
The data collected from 
the Category II diseases 
(Table 2) will be coded by 
Group (1-5) and case 
number (e.g. Group 1-1 
(H. influenza - case 1), 
Group 2-2 (hepatitis A – 
case 2) and the time 
associated in reporting 
will be assigned to each 
case. (e.g. Group 1-1 ≤ 1) 
Group 3 = hepatitis B 
Group 4 = pertussis 
Group 5 = rabies 
Group 6 = rubella 
 
(Report Date – Diagnosis 
Date ≤ 1 day) 
t  test – comparison of 
means. 
76 
 
Are the required fields 
complete for both data 
sources? 
 
The Required Fields will be 
coded alphabetically: 
dentifier = A, 
DOB = B, 
Gender = C,  
State = D,  
County = E,  
Reporting Facility Identifier = 
F,  
Program Area = G, 
Jurisdiction = H,  
Date Received by Public 
Health = I,  
Specimen Source = J,  
Date Specimen Collected = K, 
Resulted Test = L,  
Organism =M,  
Add Test Result Button = N 
The number of incomplete 
fields will be compared to 
number of incomplete fields. 
 
Ratio = #Incomplete 
fields/#Complete fields 
t test – comparison of 
means. 
 
 
Threats to Validity 
Threats to External Validity  
 There are four basic threats to external validity: Selection bias; constructs, 
methods, and confounding; the real world versus experimental world; and history effects 
maturation (Steckler & McLeroy, 2008). Selection bias was overcome because the two 
groups being compared will include all cases in West Virginia. This information was 
applied across the entire state by comparing the different regions within the state.  To 
ensure the validity of constructs such as timeliness the step from disease diagnosis to 
disease reporting was measured and compared between the two groups. If the steps in 
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reporting have changed from one group to another then this was noted and an explanation 
provided in the literature. Maturation was discussed as a threat to internal validity. 
Threats to Internal Validity 
 Maturation of individuals within the surveillance system does happen over time 
but new members of society are born and growing up within the system. The researcher 
was careful to make generalizations regarding snap shots in time versus over time. Quasi-
experimental experimental designs have several threats to internal validity including 
nonrandomization, confounding variables, and regression to the mean (Harris, 2006). 
Other weaknesses or limitations in the study design are controlling for maturation effects 
and regression to the mean. Regression to the mean and maturation are both threats to 
internal validity and possibilities in this study. Regression to the mean was a possible 
threat because the intervention may or not be the reason for an improvement in 
surveillance. Maturation effects were a possible threat in concluding that the intervention 
caused an improvement in reporting. In interuppted time-series designs there are a series 
of observations which are interrupted by the intervention (WVEDSS-NBS) then a series 
of observations after the intervention. With the series of observations before and after the 
intervention it is easier to address and control for maturation effects and regression to the 
mean.  
Ethical Procedures 
 I obtained permission from the Walden University IRB committee. A signed 
agreement was made with the state infectious disease office to gain access to the 
appropriate blinded data. All ethical concerns were addressed by receiving data that was 
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void names and other identifying characteristics of participants. Data were be protected 
again by its anonymous nature and only included pertinent information needed to 
evaluate and compare across surveillance systems. Data were stored in a separate 
portable hard drive that only I had access to and will be stored for 5 years after 
dissertation is complete and then destroyed. If there is a breach of confidentiality the 
Walden IRB committee and this committee members will be notified immediately. 
Summary 
In spite of the improvements to surveillance systems the assessment of the 
reporting of infectious disease data is imperfect and incomplete. In order to fulfill the 
purpose of this study a quasi-experimental design was used. The WVEDSS and 
WVEDSS-NBS were evaluated on a case by case basis and then compared through 
system attributes. This study recognized significant differences between WVEDSS 
(2007-2010) and WVEDSS-NBS (March 2012 to March 2014) to identify factors that 
contributed to disruptions within the surveillance systems.  Chapter 4 will discuss data 
collection, descriptive statistics of the sample, results, and a summary. 
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Chapter 4: Results  
Introduction 
The purpose of this study was to identify key areas in the process from disease 
diagnosis to disease prevention to improve the WVEDSS-NBS. The essential elements of 
the Category II VPID reported within the time frame chosen were identified; they were 
then examined quantitatively using the quasi-experimental, interrupted time-series design 
along with the diffusion of innovation theory. The difference between mean reporting 
times and the 24-hour standard between the two data sets was evaluated for timeliness. 
The required fields were assessed for completeness. Secondary data were used to 
evaluate the following research questions and hypotheses.  
 
1. Is there a difference in mean reporting time of Category II reportable infectious 
diseases between the two data systems (WVEDSS and WVEDSS-NBS) in West 
Virginia?  
2. Is there a difference from the 24-hour standard (time delay) of the infectious 
diseases under Category II of the West Virginia reportable infectious diseases for 
both data sources? 
3. Are the required fields complete for both data sources? 
 Chapter 4 will discuss the time frame for data collection, discrepancies in data 
collection from the Chapter 3 plan, baseline descriptive and demographic characteristics 
of the sample, challenges to implementation as described in Chapter 3, statistical 
assumptions, and results.  
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Data Collection 
 Data collection did not proceed as planned in Chapter 3. The time frame for data 
collection was 6 months from preliminary Walden IRB approval, October 28, 2014 to 
final approval on February 28, 2015. The time frame was extended because the West 
Virginia state epidemiology office made changes to the data request based on their access 
to the data in question. After the Walden IRB processed these changes and requests, data 
was made available. 
 The Chapter 3 plan included the following Category II Infectious Diseases:  H. 
influenza, hepatitis A, hepatitis B, pertussis, rabies, and rubella. However, while working 
with the West Virginia state epidemiology office, the Category II infectious diseases they 
chose were vaccine preventable infectious diseases because this was the most complete 
data available. Therefore, the following vaccine preventable infectious diseases were 
obtained for data analysis: diphtheria; haemophilus influenza invasive (note: only Type B 
is vaccine preventable); meningococcal disease, invasive; mumps; pertussis, and 
poliomyelitis. There was no data on diphtheria and poliomyelitis. I used haemophilus 
influenza, invasive meningococcal disease, mumps, and pertussis as Category II 
Infectious Diseases. 
 Originally, the required fields for Research Question 3 were chosen from the 
WVEDSS user guide. However, the WV state epidemiology office changed the required 
fields to the following based on their required fields: patient unique identifier, date of 
diagnosis (and date of laboratory report), date of report to public health (also known as  
PHC add time), date of birth, gender, county, state, date of symptom onset, vaccination 
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history (which can mean number of doses or date of vaccination), specimen source (if 
specimen submission is required), and the date of specimen collection (if specimen 
submission is required). The data was cleaned by the WV state epidemiology office and 
summarized by the researcher before leaving the WV state epidemiology office. Power 
analysis was performed for meningococcal disease and mumps to ensure sufficient 
sample size was obtained (p. 107). 
Descriptive Statistics of the Sample 
 The sample included all individuals within both data sets for the entire population 
of West Virginia. The sample was representative of all counties and regions of West 
Virginia. Therefore the sample was representative of the population of the state of West 
Virginia.    
Table 4 details the frequency of cases by vaccine preventable infectious disease 
(VPID), including valid cases and missing or invalid cases for WVEDSS (2009-2011) 
and WVEDSS-NBS (2012-2013). The majority of cases were pertussis, followed by H. 
influenza, meningococcal disease, and mumps. 
Table 4 
 
Frequency of cases by vaccine preventable disease (n = 714) 
 RQ1 & RQ2 RQ3 
Vaccine 
Preventable 
Infectious 
Diseases  
 
Valid cases 
2009-2011 
Missing or 
invalid 
cases 
2009-2011 
Valid cases 
2012-2013 
 
Missing or 
invalid 
cases 
2012-2013 
All available  
cases 
2009-2011 
All 
available  
cases 
2012-2013 
H. influenza 101 21 92 0 122 92 
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meningococcal 
disease 
20 3 9 0 23 9 
mumps 
8 0 6 0 8 6 
pertussis 
288 45 116 5 333 121 
Total cases 417 69 223 5 486 228 
 
Table 5 details the geographic description of cases by vaccine preventable 
infectious disease (VPID), including cases by Region for WVEDSS (2009-2011) and 
WVEDSS-NBS (2012-2013). The state is divided up into regions geographically and 
each region is assigned to a Regional Epidemiologist who oversees these areas. The 
majority of cases were in Region 2, 3, 5 and 7. 
Table 5 
 
Geographic description of cases by region (n = 905) 
                                           Regions    
Vaccine 
Preventable 
Infectious 
Diseases  
    1      2      3 
 
    4     5    6    7    8 
H. influenza 
  2009-2011 
  2012-2013 
 
21 
12 
 
27 
15 
 
22 
28 
 
11 
10 
 
13 
6 
 
9 
5 
 
7 
7 
 
12 
6 
meningococcal 
disease  
2009-2011 
2012-2013 
mumps 
  2009-2011 
  2012-2013 
 
 
1 
0 
 
 
0 
1 
 
 
3 
0 
 
 
2 
1 
 
 
2 
4 
 
 
3 
0 
 
 
5 
0 
 
 
0 
0 
 
 
4 
1 
 
 
0 
0 
 
 
2 
1 
 
 
2 
2 
 
 
5 
1 
 
 
1 
2 
 
 
1 
2 
 
 
0 
0 
pertussis 
  2009-2011 
  2012-2103 
 
29 
32 
 
17 
14 
 
41 
29 
 
35 
14 
 
126 
14 
 
12 
3 
 
46 
5 
 
27 
6 
Total Cases 96 178 147 75 164 54 128 63 
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Results 
Research Question 1  
 An independent-samples, t test was run to determine if there were differences in 
mean reporting times between 101 H. influenza WVEDSS cases and 92 WVEDSS-NBS 
H. Influenza cases. The mean reporting times (days) were shorter for WVEDSS H. 
Influenza cases (M = 5.19, S.D. = 5.72) than for WVEDSS-NBS H. Influenza cases (M = 
17.22, S.D. = 19.43). The assumption of homogeneity of variances was violated, as 
assessed by Levene’s test for equality of variances (p < .001). Equal variances were not 
assumed and there was a statistically significant difference in mean reporting times for H. 
influenza between WVEDSS and WVEDSS-NBS, t (105.338) = 5.716, p < .05. 
Therefore, we can reject the null hypothesis and accept the alternative hypothesis. 
 An independent-samples, t test was run to determine if there were differences in 
mean reporting times between 20 meningococcal disease WVEDSS cases and 9 
WVEDSS-NBS meningococcal disease cases. The mean reporting times were shorter for 
WVEDSS meningococcal disease cases (M = 1.55, S.D. = 2.44) than for WVEDSS-NBS 
meningococcal disease cases (M = 8.00, S.D. = 6.97). The assumption of homogeneity of 
variances was violated, as assessed by Levene’s test for equality of variances (p < .001). 
Equal variances were not assumed and there was a statistically significant difference in 
mean reporting times for meningococcal disease between WVEDSS and WVEDSS-NBS, 
t (8.895) = 2.705, p = .024. Therefore, we can reject the null hypothesis and accept the 
alternative hypothesis. 
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 An independent-samples, t test was run to determine if there were differences in 
mean reporting times between 8 mumps WVEDSS cases and 6 WVEDSS-NBS mumps 
cases. The mean reporting times were shorter for WVEDSS mumps cases (M = 3.88, S.D. 
= 2.90) than for WVEDSS-NBS mumps cases (M = 3.83, S.D. = 4.92). There was 
homogeneity of variances for mean reporting times for WVEDSS and WVEDSS-NBS, as 
assessed by Levene’s test for equality of variances (p = .077).  Equal variances were 
assumed and there was not a statistically significant difference in mean reporting times 
for mumps between WVEDSS and WVEDSS-NBS, t (12) = 0.020, p = 0.99. Therefore, 
we can reject the alternative hypothesis and fail to reject the null hypothesis. 
 An independent-samples, t test was run to determine if there were differences in 
mean reporting times between 289 pertussis WVEDSS cases and 116 WVEDSS-NBS 
pertussis cases. The mean reporting times were shorter for WVEDSS pertussis cases (M = 
5.01, S.D. = 22.05) than for WVEDSS-NBS pertussis cases (M = 26.01, S.D. = 37.44). 
The assumption of homogeneity of variances was violated, as assessed by Levene’s test 
for equality of variances (p < .001). Equal variances were not assumed and there was a 
statistically significant difference in mean reporting times for pertussis between 
WVEDSS and WVEDSS-NBS, t (148.096) = 5.659, p < .05. Therefore, we can reject the 
null hypothesis and accept the alternative hypothesis. 
Table 6 details the mean reporting time (MRT) of cases by vaccine preventable 
infectious disease (VPID), including the number of cases before and after the 
intervention, t value, dF, and the P values for WVEDSS (2009-2011) and WVEDSS-NBS 
(2012-2013). The majority of MRT for WVEDSS cases were shorter then MRT for 
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WVEDSS-NBS cases. Meaning that timeliness was better before the intervention of the 
Web-based server. 
 
Table 6  
 
Cases by mean reporting time (n = 713) 
RQ 1        
Vaccine 
Preventable 
Infectious 
Diseases 
WVEDSS 
Cases 
2009-
2011 
WVEDSS-NBS 
Cases  
2012-2013 
MRT 
WVEDSS 
09-11 
MRT 
WVEDSS-
NBS 
12-13 
t value 
 
 
 
 dF P 
valu
e 
H. influenza 
 
meningococcal 
disease 
 
mumps 
 
pertussis 
101 
 
20 
 
8 
 
289 
92 
 
9 
 
6 
 
116 
M=5.19, 
S.D.=5.72 
M=1.55, 
S.D.=2.44 
M=3.88, 
S.D.=2.90 
M=5.01, 
S.D.=22.05 
M=17.22, 
S.D.=19.43 
M=8.00, 
S.D.=6.97 
M=3.83, 
S.D.=4.92 
M=26.01, 
S.D.=37.44 
5.716 
 
2.705 
 
0.020 
 
5.659 
105.338 
 
8.895 
 
12 
 
148.096 
< .05 
 
.024 
 
0.99 
 
< .05 
 
Research Question 2  
 An independent-samples, t test was run to determine if there were differences in 
24-hour standard reporting times between 101 H. influenza WVEDSS cases and 92 
WVEDSS-NBS H. influenza cases. The 24-hour standard reporting times were shorter 
for WVEDSS H. influenza cases (M = 1.65, S.D. = 0.48) than for WVEDSS-NBS H. 
influenza cases (M = 1.96, S.D. = 0.21). The assumption of homogeneity of variances 
was violated, as assessed by Levene’s test for equality of variances (p < .001). Equal 
variances were not assumed and there was a statistically significant difference in mean 
reporting times for H. influenza between WVEDSS and WVEDSS-NBS, t (138.249) = 
5.809, p < .05. Therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
86 
 
 Independent-samples, t test was run to determine if there were differences in 24-
hour standard reporting times between 20 meningococcal disease WVEDSS cases and 9 
WVEDSS-NBS meningococcal disease cases. The 24-hour standard reporting times were 
shorter for WVEDSS meningococcal disease cases (M = 1.35, S.D. = 0.48) than for 
WVEDSS-NBS meningococcal disease cases (M = 2.00, S.D. = 0). The assumption of 
homogeneity of variances was violated, as assessed by Levene’s test for equality of 
variances (p < .001). Equal variances were not assumed and there was a statistically 
significant difference in the 24-hour standard reporting times for meningococcal disease 
between WVEDSS and WVEDSS-NBS, t (19.000) = 5.940, p < .05. Therefore, we can 
reject the null hypothesis and accept the alternative hypothesis. 
 Independent-samples, t test was run to determine if there were differences in 24-
hour standard reporting times between 8 mumps WVEDSS cases and 6 WVEDSS-NBS 
mumps cases. The 24-hour standard reporting times were shorter for WVEDSS mumps 
cases (M = 1.88, S.D. = 0.35) than for WVEDSS-NBS mumps cases (M =1.50, S.D. = 
0.55). The assumption of homogeneity of variances was violated, as assessed by 
Levene’s test for equality of variances (p = .024). Equal variances were not assumed and 
there was a statistically significant difference in the 24-hour standard reporting times for 
mumps between WVEDSS and WVEDSS-NBS, t (8.052) = 1.464, p = .181. Therefore, 
we can reject the null hypothesis and accept the alternative hypothesis. 
 Independent-samples, t test was run to determine if there were differences in 24-
hour standard reporting times between 288 pertussis WVEDSS cases and 116 WVEDSS-
NBS pertussis cases. The 24-hour standard reporting times were shorter for WVEDSS 
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pertussis cases (M = 1.52, S.D. = 0.50) than for WVEDSS-NBS pertussis cases (M = 
1.88, S.D. = 0.33). The assumption of homogeneity of variances was violated, as assessed 
by Levene’s test for equality of variances (p < .001). Equal variances were not assumed 
and there was a statistically significant difference in the 24-hour standard reporting times 
for pertussis between WVEDSS and WVEDSS-NBS, t (319.902) = 8.387, p < .05. 
Therefore, we can reject the null hypothesis and accept the alternative hypothesis. 
Table 7 details the 24-hour standard reporting time of cases by vaccine 
preventable infectious disease (VPID), including the number of cases before and after the 
intervention, t value, dF, and the P values for WVEDSS (2009-2011) and WVEDSS-NBS 
(2012-2013). None of the cases before or after the intervention meet the 24-hour standard 
reporting times for Category II Infectious Diseases. In fact, the times actually increased 
after the intervention of the Web-based server.  
 
Table 7 
Cases by 24-hour standard reporting time (n = 712) 
RQ 2        
Vaccine 
Preventable 
Infectious 
Diseases 
WVEDSS 
Cases 
2009-2011 
WVEDSS-NBS 
Cases  
2012-2013 
24-hour 
standard 
WVEDSS 
09-11 
24-hour 
standard 
WVEDSS-
NBS 
12-13 
t value 
 
 
 
 dF P value 
H. influenza 
 
meningococcal 
disease 
 
mumps 
 
pertussis 
101 
 
20 
 
8 
 
288 
92 
 
9 
 
6 
 
116 
M=1.65, 
S.D.=0.48 
M=1.35, 
S.D.=0.48 
M=1.88, 
S.D.=0.35 
M=1.52, 
S.D.=0.50 
M=1.96, 
S.D.=0.21 
M=2.00, 
S.D.=0.00 
M=1.50, 
S.D.=0.55 
M=1.88, 
S.D.=0.33 
5.809 
 
5.940 
 
1.464 
 
8.387 
138.249 
 
19.000 
 
8.052 
 
319.902 
< .05 
 
< .05 
 
.181 
 
< .05 
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Research Question 3  
 An independent-samples, t test was run to determine if there were differences in 
Incomplete Fields/Complete Fields Ratio between 122 H. influenza WVEDSS cases and 
92 WVEDSS-NBS H. influenza cases. The Incomplete/Complete Ratio was less 
complete for WVEDSS H. influenza cases (M = 0.32, S.D. = 0.24) than for WVEDSS-
NBS H. influenza cases (M = 0.07, S.D. = 0.07). The assumption of homogeneity of 
variances was violated, as assessed by Levene’s test for equality of variances (p < .001). 
Equal variances were not assumed and there was a statistically significant difference in 
the Incomplete to Complete Ratio for H. influenza between WVEDSS and WVEDSS-
NBS, t (147.088) = 11.221, p < .05. Therefore, we can reject the null hypothesis and 
accept the alternative hypothesis. 
 Independent-samples, t test was run to determine if there were differences in 
Incomplete Fields/Complete Fields Ratio between 20 meningococcal disease WVEDSS 
cases and 9 WVEDSS-NBS meningococcal disease cases. The Incomplete/Complete 
Ratio was less complete for WVEDSS meningococcal disease cases (M = 0.22, S.D. = 
0.05) than for WVEDSS-NBS meningococcal disease cases (M = 0.02, S.D. = 0.07). 
There was homogeneity of variances for the 24-hour standard reporting time for 
WVEDSS and WVEDSS-NBS, as assessed by Levene’s test for equality of variances (p 
= .228). Equal variances were assumed and there was not a statistically significant 
difference in the Incomplete to Complete Ratio for meningococcal disease between 
WVEDSS and WVEDSS-NBS, t (30) = 8.668, p > .05. Therefore, we can reject the 
alternative hypothesis and fail to reject the null hypothesis. 
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 Independent-samples, t test was run to determine if there were differences in 
Incomplete Fields/Complete Fields Ratio between 8 mumps WVEDSS cases and 6 
WVEDSS-NBS mumps cases. The Incomplete/Complete Ratio is less complete for 
WVEDSS mumps cases (M = 0.13, S.D. = 0.57) than for WVEDSS-NBS mumps cases 
(M = 0.10, S.D. = 0.00). The assumption of homogeneity of variances was violated, as 
assessed by Levene’s test for equality of variances (p = .002). Equal variances were not 
assumed and there was a statistically significant difference in the Incomplete to Complete 
Ratio for mumps between WVEDSS and WVEDSS-NBS, t (7.000) = 1.528, p = .170. 
Therefore, we can reject the null hypothesis and accept the alternative hypothesis. 
 Independent-samples, t test was run to determine if there were differences in 
Incomplete Fields/Complete Fields Ratio between 333 pertussis WVEDSS cases and 121 
WVEDSS-NBS pertussis cases. The Incomplete/Complete Ratio was less complete for 
WVEDSS pertussis cases (M = 0.26. S.D. = 0.11) than for WVEDSS-NBS pertussis cases 
(M = 0.03, S.D. = 0.08). The assumption of homogeneity of variances was violated, as 
assessed by Levene’s test for equality of variances (p = .001). Equal variances were not 
assumed and there was a statistically significant difference in the Incomplete to Complete 
Ratio for pertussis between WVEDSS and WVEDSS-NBS, t (284.892) = 24.544, p < .05. 
Therefore, we can reject the null hypothesis and accept the alternative hypothesis. 
Table 8 details the completeness (incomplete/complete) of cases by vaccine 
preventable infectious disease (VPID), including the number of cases before and after the 
intervention, t value, dF, and the P values for WVEDSS (2009-2011) and WVEDSS-NBS 
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(2012-2013). All WVEDSS-NBS cases were less complete after the intervention of the 
Web-based server. 
Table 8 
Cases by completeness ratio  (n = 712) 
RQ 3        
Vaccine 
Preventable 
Infectious 
Diseases 
WVEDSS 
Cases 
2009-
2011 
WVEDSS-
NBS 
Cases  
2012-2013 
24-hour 
standard 
WVEDSS 
09-11 
24-hour 
standard 
WVEDSS-
NBS 
12-13 
t value 
 
 
 
 dF P 
valu
e 
H. influenza 
 
meningococcal 
disease 
 
mumps 
 
pertussis 
122 
 
20 
 
8 
 
333 
92 
 
9 
 
6 
 
121 
M=0.32, 
S.D.=0.24 
M=0.22, 
S.D.=0.05 
M=0.13, 
S.D.=0.57 
M=0.26, 
S.D.=0.11 
M=0.07, 
S.D.=0.07 
M=0.02, 
S.D.=0.07 
M=0.10, 
S.D.=0.00 
M=0.03, 
S.D.=0.08 
11.221 
 
8.668 
 
1.528 
 
24.544 
147.088 
 
30 
 
7.000 
 
284.892 
< 
.05 
 
< 
.05 
 
.170 
 
< 
.05 
 
Summary 
 There was a statistically significant difference between means (p < .05) for all 
research questions and vaccine preventable infectious diseases except for mumps mean 
reporting time for Research Question 1. For this question, there was not a statistically 
significant difference between means (p > .05), and therefore, we fail to reject the null 
hypothesis. For research question 1, all the vaccine preventable diseases mean reporting 
times were longer after the intervention. There was a statistically significant difference 
between means (p < .05) for all research questions and vaccine preventable infectious 
diseases except for mumps mean reporting time for Research Question 2. For research 
question 2, three vaccine preventable infectious diseases were longer after the 
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intervention and mumps were longer before the intervention. There was a statistically 
significant difference between means (p < .05) for all research questions and vaccine 
preventable infectious diseases except for meningococcal disease for Research Question 
3. Therefore, for meningococcal disease we can reject the alternative hypothesis and fail 
to reject the null hypothesis. All the vaccine preventable diseases for Research Question 3 
were less complete after intervention. 
1. Is there a difference in mean reporting time of Category II reportable infectious 
diseases between the two data systems (WVEDSS and WVEDSS-NBS) in West 
Virginia?  
a. H. influenza 
  There was a statistically significant difference between means (p <  
  .05), and therefore, we can reject the null hypothesis and accept the  
  alternative hypothesis. 
b. meningococcal disease 
  There was a statistically significant difference between means (p <  
  .05), and therefore, we can reject the null hypothesis and accept the  
  alternative hypothesis. 
c. mumps 
There was not a statistically significant difference between means (p > .05), 
and therefore, we can reject the alternative hypothesis and fail to reject the 
null hypothesis. 
d. pertussis 
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There was a statistically significant difference between means (p < .05), 
and therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
2. Is there a difference from the 24-hour standard (time delay) of the infectious diseases 
under Category II of the West Virginia reportable infectious diseases for both data 
sources? 
a. H. influenza 
There was a statistically significant difference between means (p < .05), 
and therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
b. meningococcal disease 
There was a statistically significant difference between means (p < .05), 
and therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
c. mumps 
There was a statistically significant difference between means (p < .05), 
and therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
d. pertussis 
There was a statistically significant difference between means (p < .05), 
and therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
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3. Are the required fields (identifier, dob, gender, state, county, reporting facility 
identifier, program area, jurisdiction, date received by public health, specimen source, 
date specimen collected, resulted test, organism, add test result button) complete for 
both data sources? 
a. H. influenza 
There was a statistically significant difference between means (p < .05), 
and therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
b. meningococcal disease 
There was not a statistically significant difference between means (p > .05), 
and therefore, we can reject the alternative hypothesis and fail to reject the 
null hypothesis. 
c. mumps 
There was a statistically significant difference between means (p < .05), 
and therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
d. pertussis 
There was a statistically significant difference between means (p < .05), 
and therefore, we can reject the null hypothesis and accept the alternative 
hypothesis. 
Chapter 5 will discuss the interpretations, limitations, recommendations, and 
implications of these findings. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction  
 The purpose of this study was to pinpoint crucial steps in the surveillance process 
from disease diagnosis to disease prevention (regional epidemiologists report to state 
epidemiology office) to improve the evaluation of the timeliness and completeness of the 
surveillance system. A quasi-experimental, interrupted time-series design, with non-
random assignment of groups was used to compare the infectious disease cases that were 
manually entered into WVEDSS between 2009 and 2012 and those that were entered into 
the newly developed WVEDSS-NBS, which was established on Web-based server in 
March 2012. In this study, data were collected from March 2012 through December 
2013. Timeliness was assessed by the difference in mean reporting times (Report date – 
Diagnosis Date) and the 24-hour standard reporting time (Report date – Diagnosis date ≤ 
1), using the two independent samples t test. The required fields (patient unique 
identifier, date of diagnosis, and date of laboratory report), date of report to public health 
(also known as PHC add time), date of birth, gender, county, state, date of symptom 
onset, vaccination history (which can mean number of doses or date of vaccination), 
specimen source (if specimen submission is required), and the date of specimen 
collection (if specimen submission is required) were evaluated for completeness by 
comparing the incomplete fields/complete fields ratio using the two independent samples 
t test.  Four Vaccine-Preventable Category II Infectious Diseases were used:  H. 
influenza, meningococcal disease, mumps, and pertussis.  
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Summary of Key Findings  
 There was a statistically significant difference (p < 0.5) between mean reporting 
times of Category II vaccine-preventable infectious diseases between the two data 
systems (WVEDSS and WVEDSS-NBS) in West Virginia. The study rejected the null 
hypothesis and accepted the alternative hypothesis for H. influenza, meningococcal 
disease, and pertussis. For mumps we failed to reject the null hypothesis. There was a 
difference from the 24-hour standard of the vaccine preventable infectious diseases under 
Category II VPID of the West Virginia reportable infectious diseases for both data 
sources. We rejected the null hypothesis and accepted the alternative hypothesis for H. 
Influenza, meningococcal disease, mumps, and pertussis. The required fields were 
complete for both data sources. We rejected the null hypothesis and accepted the 
alternative hypothesis for H. influenza, mumps, and pertussis.  The study failed to reject 
the null hypothesis for meningococcal disease. 
Interpretation of the Findings 
 The findings disconfirm that timeliness of reporting to the public health 
department would improve after the intervention. The mean reporting time for all 
infectious diseases increased after the intervention and in some cases the mean reporting 
times doubled and tripled. The majority of cases from both datasets did not meet the 24-
hour standard for reporting Category II infectious diseases. This indicates that the cases 
from before and after the intervention were not timely.  
 These findings confirm that the ratio of incomplete to complete fields improved 
after the intervention of a Web-based server. All fields were found to be less complete 
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after the intervention. This means that the completeness improved after switching to the 
Web-based server, WVEDSS-NBS, in March of 2012.  
 This data extends knowledge in the discipline. which is illustrated by comparing 
the data with what was found in the peer-reviewed literature described in Chapter 2. 
Heisey-Grove et al. (2011) agreed that the conventional system was always incomplete 
especially in the area of vital risk prevention data fields. Doyle et al.(2002) stated that 
active surveillance has proven to have a more complete case record than passive 
surveillance. According to Sickbert-Bennett et al. (2011) disease completeness varied not 
only by disease in their retrospective cohort study but also by healthcare system. In a 
study performed by Effler et al. (1999) they found the electronic format to be far superior 
to the conventional paper or manual format. However, the results of this study indicate 
that both data systems had complete reporting with data being more complete after the 
intervention.  
 Timeliness is a key element and should be used as a consistent evaluation and 
measurement tool of surveillance systems (Yoo et al., 2009). Jajosky and Groseclose 
(2004) stated that timeliness is a quantitative indicator of the surveillance systems 
reliability and validity and is used to determine any time delays between operational 
phases. Reijn et al. (2011) stated that infectious disease surveillance systems (IDSS) 
should be regularly evaluated for each step in the system for each disease within the 
system. The WV state epidemiology office can use the data from this study on timeliness 
to evaluate where the time lag exists in the process from disease diagnosis to disease 
reporting.   
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 Reijn et al. found that the proportion of infectious diseases reported to the LHD 
varied by disease. Lazarus et al. (2009) stated that despite all of the improvements made 
in surveillance systems across the country some important internal mechanisms still 
depend on people. Even though we have come a long way and improved several 
qualitative and quantitative aspects of infectious disease reporting training and integrating 
primary stakeholders within the system remains essential. Nicolay et al. (2010) stated that 
research has proven that implementation of electronic reporting will decrease timeliness 
and increase the completeness of surveillance statistics. The literature and the results of 
this study indicate that implementing electronic reporting may not be the reason that the 
reporting for vaccine preventable infectious diseases was not timely. An error may be 
occurring on the human side of the reporting process. 
 Incorporating an electronic evaluation system for WVEDSS-NBS can help 
epidemiologists’ evaluate the system for timeliness. Madoff, Fisman, and Kass-Hout 
(2011) concluded that incorporating the Internet into surveillance reporting would 
improve timeliness, sensitivity, and completeness of surveillance system data. 
Computerized technology allows for the assessment of timeliness to be completed 
routinely on each step in the public health surveillance system. Although completeness 
improved in this study timeliness of the system for Category II VPID was longer after the 
intervention.  
 Electronic reporting, electronic health records, and electronic laboratory reporting 
have the potential to improve all system attributes. Wurtz and Cameron (2005) illustrated 
that despite these obvious improvements in infectious disease surveillance, physicians 
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must still do their part in submitting a comprehensive and well-timed case report.  When 
analyzing the data it was discovered that although the completeness of 
incomplete/complete fields improved after the intervention timeliness actually increased. 
One reason for this may have been that the actually intervention, going to a Web-based 
server, may not have been communicated to the stakeholders. The physicians and other 
health professionals that diagnose patients and record the diagnosis date may not have 
been aware that a change was taken place in reporting. A qualitative study surveying this 
group of stakeholders could be done in the future to examine this line of reasoning.  
 On the other side, the WV state epidemiologist office assigns epidemiologists to 
specific regions in the state. The response of these individuals on a questionnaire for 
report date fields may shed some light on the increased timeliness for infectious diseases 
in Category II. These regional epidemiologists are the leading innovators and adopters in 
their field. The process of diffusion is first identified as an informal planning process that 
is followed by a formal structured procedure driven by social networking within the 
organization. 
 It may be that during the implementation of the WVEDSS-NBS the technological  
difficulties surpassed the epidemiologist’s ability to report cases to the state office in a 
timely manner. Perhaps a more formal process of dissemination should have been 
implemented so that essential stakeholders were prepared for implementing data on time. 
Researchers contesting the paradigms of diffusion research have illustrated that those 
new technologies previously integrated using only simple diffusion should have gone 
through a more formal dissemination process (Greenhalgh et al., 2004). For instance, 
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Rogers (2003) suggested using the technology cluster model for technological 
innovations that include more than one technology within the system. The WV state 
epidemiology office will need to consider all aspects of the innovation and coordinate a 
strategy for implementation that includes all the stakeholders in the system. 
 One area that was not covered in this study was the time from disease onset to 
diagnosis. Yoo et al. (2009) stated that timely reporting is effected most by the interval 
from disease inception to diagnosis. As electronic disease reporting improves the 
evaluation of this step in the surveillance process can be incorporated into the 
surveillance process. Yoo et al. (2009) stated that previous research has indicated that the 
surveillance steps of infectious disease reporting vary from system to system and from 
one infectious disease to another. In this study all Category II VPID were measured for 
timeliness in the same manner.  
 The most important aspect in evaluating the timeliness of a surveillance system is 
to establish a standard definition. Timeliness was defined in terms of mean reporting time 
and the 24-hour standard. Jajosky and Groseclose (2004) collected data on the National 
Notifiable Disease Surveillance System (NNDSS) and suggested using the earliest known 
date of disease onset as the starting point for the measurement of timeliness, varying by 
disease. The comparison of timeliness from paper to a Web-based server illustrated key 
factors causing delays in the timely reporting of infectious diseases. These key factors 
may assist epidemiologists in improving the timeliness of the WVEDSS-NBS. 
 Results of the Colorado Electronic Disease Reporting System (CEDRS) prompted 
training of disease investigators to fill out intake forms completely with the hope that 
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future evaluations will yield improved timeliness and more complete data. Vogt, Spittle, 
Cronquist, and Patnaik (2006) illustrated how a LHD could evaluate the CEDRS for 
timeliness and completeness. Timeliness was defined as the time period between 
“specimen collection date” and “report date” for each patient and they compared them 
through distribution of means. In this study I did not have a problem with the 
completeness of the “diagnosis date” or “report date”. However, when the WV State 
Epidemiologist Office may run into problems here when they evaluate the entire 
surveillance system to establish their baseline. 
Some of the most common reasons for delayed reporting are patient’s recognition 
of symptoms, communication issues, missing data, incorrect data, disease specific 
incubation periods, and laboratory-related delays. Reijn et al. (2011) illustrated that 
electronic laboratory reporting (ELR) has improved the timeliness in some nations and 
concluded that an international standardization method for measuring timeliness be 
supported. The WVEDSS-NBS has not implemented ELR within its system. The results 
indicated that some fields had incorrect data and missing data, which may be resolved by 
instilling a warning message within the data entry feature. 
The evaluation of data from surveillance systems for timeliness varies because 
each study examines different diseases and measures of timeliness. Yoo et al.  (2009) 
evaluated over 40,000 infectious disease records from an electronic system that collected 
data in 2000. They found that the greatest time delay stemmed from the delay in 
diagnosis from the clinical side and from the excess time spent on lengthy laboratory 
tests. They found that the total time from disease onset to reporting to the local health 
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department ranged from six to twenty days and varied from one disease to another. In this 
study the total time from disease onset to reporting to the state health department ranged 
from one to 366 days. 
Most studies found that electronic reporting resulted in an improvement in all 
system attributes especially timeliness. Effler et al.  (1999) compared an electronic 
reporting system to the previous conventional system and found a 2.3 fold increase in 
infectious disease reporting with the new system. The CDC (2005) stated that in New 
Jersey, which has a Web-based server like WVEDSS-NBS that they implemented in 
2001, the number of cases reported from 2002 to 2004 doubled and that the average days 
for case reporting dropped from 28 days in 2002 to 3-4 days in 2004. In this study the 
mean reporting times increased after the switch to a Web-based server and the 24-hour 
standard reporting times were not met. 
Even though most states have adapted to national guidelines by using the NEDSS 
equivalent software to upgrade their paper based systems to electronic or Web-based 
servers many problems still exist in establishing standards for information exchange. As 
the interface between clinicians and public health officials improve the data becomes 
more streamlined and universal. In the past health data was faxed, mailed, or emailed to 
the local or regional epidemiologist to be entered into the state system. The 
epidemiologist entered this data into the system sometimes weeks after the information 
had been received or the notifiable condition had transpired. The CDC (2005) reported 
that many (10-85%) of these cases never made it to the national level and previously 
states used over 100 different systems to send reports to the CDC. A review of the 
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literature has revealed that many definitions and standards of measurement for timeliness 
have been used in the past. I used the CDC’s recommendations for the measurement for 
timeliness and the incomplete/complete ratio for the completeness to prepare a 
foundation for future measurements on WVEDSS-NBS. West Virginia may find that they 
need to implement ELR to improve the timeliness of WVEDSS-NBS. 
Electronic disease reporting has become the standard by which all other reporting 
is to be compared. According to several researchers (Reijn et al., 2011; Yoo et al., 2009; 
Nicolay et al., 2010; Doyle et al., 2002) electronic disease reporting has improved the 
timeliness of infectious disease outbreak notification.  In addition these authors and the 
CDC (2005) recommend that states integrate ELR into their existing systems to improve 
timeliness because laboratory tests are used to confirm most infectious diseases, labs are 
important members of the system, and laboratories can be used for other aspects of public 
health surveillance.  
As West Virginia learns more about electronic disease reporting process and 
builds the state surveillance infrastructure to comply with national standards, the 
evaluation process will improve. Nicolay et al. (2010) stated that research has proven that 
implementation of electronic reporting will decrease timeliness and increase the 
completeness of surveillance statistics. Electronic data and evaluation methods at the 
local, state, national, and international level allows for more complete assessment of 
infectious diseases and their spread around the globe. 
Completeness was measured by the ratio of incomplete fields to complete fields 
of data items required by the West Virginia state epidemiology office. According to 
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Doyle et al. (2002) infectious disease reporting completeness identifies those notifiable 
cases that have been reported to the local health department. The completeness of intake 
forms is crucial to the proper accounting of cases of infectious disease within a 
population. Without this vital information to guide the epidemiologist and other public 
health officials in the diagnosis of notifiable infectious diseases, outbreaks may be missed 
and epidemics may occur.  Although this study indicated an improvement in 
completeness overall there is room for WVEDSS-NBS completeness to improve. 
It is important to evaluate infectious disease completeness by each disease under a 
specific Category. Jajosky and Groseclose (2004) stated that mandatory infectious 
disease reporting in the U.S. varies from 9% to 99% and that active surveillance 
completeness was much better than passive disease surveillance systems completeness. 
The NEDSS has outlined standards for the evaluation of surveillance systems to improve 
the accuracy, completeness, and timeliness of infectious disease reporting in the United 
States. I evaluated disease completeness by assessing the ratio of incomplete to complete 
fields by each infectious disease under a specific Category on both datasets intake forms. 
The NEDSS recommends that each state follow guidelines for submitting 
infectious disease data. Clinicians in West Virginia may need training on the new format 
of infectious disease reporting in order to improve timeliness and completeness. 
Clinicians outreach programs are essential according to Lazarus et al. (2009) because 
despite considerable progress in electronic reporting many significant surveillance 
procedures still rely on practitioner’s manual entry and submission of data. Training 
105 
 
health professionals on WVEDSS-NBS and other aspects of electronic disease reporting 
can improve the timeliness and completeness of the system. 
In the past the measurement and evaluation of disease completeness was a 
difficult task. Doyle et al.  (2002) explained reasons from the literature for incomplete 
infectious disease reporting in the past. The reasons included safety and privacy issues, 
misinterpretation of the law regarding notifiable conditions, ignorance of required 
infectious disease to report, clueless about where and to whom to report, and inadequate 
punishment for not reporting. Even at the national level the evaluation of the NEDSS is 
incomplete. According to Sickbert-Bennett et al. (2011) the evaluation of the NEDSS in 
the United States is inadequate and previous studies differ on their assessment of 
reporting completeness. I evaluated disease completeness in this study using the 
incomplete/complete data fields across diseases in Category II VPID. Doyle et al. (2002) 
illustrated that the complete integration of all systems as one automated systems is the 
future of surveillance systems, ELR, and the EHR. The NEDSS and the CDC are 
restructuring the clinical system and public health systems into one complete health 
system in the United States. West Virginia has begun infrastructure building and that type 
of work does not happen over night.  
Limitations of the Study 
 Permission was obtained to use all the cases under Category II Vaccine 
Preventable Infectious Diseases from the state of West Virginia epidemiology office. 
This eliminated the limitation from using data from two different time periods, sample 
data and reduced selection bias, statistical analysis and Levene’s test also helped in 
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controlling for bias, maturation effects, and regression to the mean. Regression to the 
mean and maturation are both threats to internal validity and possibilities in this study. 
Regression to the mean is a possible threat because the intervention may or not be the 
reason for an improvement in surveillance. Maturation effects are a possible threat in 
concluding that the intervention caused an improvement in reporting.   
 Power analysis was conducted to ensure that the sample size from available 
secondary data met a minimum level of 95%. The following parameters were included in 
G*Power 3.1.7 (Faul, Erdfelder, Lang, & Buchner, 2007; Faul, Erdfelder, Buchner, & 
Lang, 2009): Test family (Exact), Statistical test (Inequality, two independent groups 
(Fisher’s exact test), Type of power analysis (A priori: Compute required sample size), 
two tails, proportions dataset 1 (WVEDSS) = x1, proportion dataset 2 (WVEDSS-NBS) 
= x2, α = 0.05, Power (1- β err problem) = 0.95, and allocation ratio (N1/N2) = 2. The 
proportion sizes (x1, x2) were determined from the West Virginia DHHR website on 
infectious disease surveillance cases from 2007-2014. The following outputs were 
determined: sample size haemophilus influenza invasive 1 = 12, group 2 = 24, total 
sample size = 36; sample size meningococcal disease group 1 = 1, group 2 = 3, total 
sample size = 4; sample size mumps group 1 = 3, group 2 = 5, total sample size = 8; 
sample size pertussis group 1 = 21, group 2 = 41, total sample size = 62. Based on these 
calculations from G*Power 3.1.7 the sample size was efficient for all VPID. 
Recommendations 
 Recommendations for further research are grounded in the strengths and 
limitations of the current study as well as the literature reviewed in chapter 2.  
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Recommendations for further research are based on the results of this study. A formal 
process for including stakeholders and healthcare professionals should be implemented to 
ensure proper adherence to infectious disease reporting. A survey of these individuals and 
the regional epidemiologists may shed light into why the timeliness of vaccine 
preventable infectious diseases actually increased after the intervention. 
 Recommendations for action are based on the results of this study and the 
literature. An evaluation of all infectious diseases in all categories should be performed to 
better understand the timeliness and completeness of the intervention. Electronic 
reminders should be sent to regional epidemiologists and healthcare professionals to 
reinforce timely reporting according to categories. A plan for action may include 
updating the WVEDSS-NBS to the next level, the National Electronic Disease 
Surveillance System (NEDSS) To do so, the WV Department of Health and Human 
Services would need to incorporate ELR into its current surveillance system. Another 
plan of action is to introduce community awareness programs that will engage the health 
professionals in the system. 
 Areas identified for improvement in regard to the diffusion of innovation theory 
were identified at the macro level of organization.  At the micro level the WV state 
epidemiology office’s level of communication and social networking were well 
organized.  However, areas in dissemination at the macro level to public health officials 
and healthcare professionals throughout the state needs to be refined and reworked.  
Areas they need to address are stakeholder communication, social networking, and 
implementation of Rogers (2003) technology cluster model for technology innovations.  
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A SWOT analysis (Attaway, Jacobsen, Falconer, Manca, & Waters, 2014) of the tasks 
needed for a macro level dissemination would identify their current strengths, 
weaknesses, opportunities, and threats (SWOT) and all potential improvements that need 
to be made.  Furthermore, incorporating Geographical Information Systems (GIS) 
(Busgeeth, 2004 & Ruiz, Tedesco, & McTighe, 2004) into outbreak management would 
allow visualization of the data to aid in policy creation and outbreak preparedness. 
Implications 
 The results of this study provide health departments with the information and 
tools to address the fundamental factors that help public health officials assess the 
population’s health. Integration of the EHR with WVEDSS-NBS allows health 
professionals to have instant access to the most recent health data allowing local health 
departments to effect social change. We want to reduce morbidity/mortality and one way 
to do that is through improving reporting times so that we can better control disease 
outbreaks. Therefore we need timely and complete forms to work appropriately. Colbert 
and Harrison (2011) stated that to accomplish these tasks more complete epidemiological 
and surveillance data must be acquired to understand the complex matrix of health 
disparities. A more complete evaluation of surveillance system data needs done by West 
Virginia to identify the incidence of Category II infectious diseases and assess the 
effectiveness of the LHD by examining, comparing, and evaluating the old WVEDSS and 
the newly developed WVEDSS-NBS for these system attributes (identified as timeliness 
and completeness). I examined the environment in which the surveillance systems 
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operated (by utilizing the diffusion of innovation theory) in order to identify areas for 
improvement and sustain social change.   
 Implications for social change begin at the individual level when one adopter 
understands that their actions can bring about the changes needed. It takes one 
epidemiologist to see that decreasing the timeliness of WVEDSS-NBS can save money 
and improved reporting can reduce the length of outbreaks. The decreased spread of 
infectious diseases in the state will reduce mortality and morbidity from disease 
outbreaks. Community awareness programs and academic research in the area of timely 
reporting can influence policies to improve the timeliness of reporting. The medical 
culture and society in West Virginia would be enriched by a more reliable and valid 
approach to infectious disease reporting in the state. 
Conclusion 
 The results of the study indicate that the timeliness was quite poor with Category 
II VPID. However, the completeness improved after the introduction of the Web-based 
server. When implementing an electronic intervention, like a Web-based server, it is 
essential to build a communication network to support electronic disease surveillance. 
According to Watkins et al. (2009) system attributes for measuring the sensitivity of a 
surveillance system should include timeliness, completeness, and the geographic and 
demographic data of the population. On going evaluation methods will need to be 
implemented by the State of West Virginia to ensure that timeliness and completeness of 
surveillance system data improves over time. Healthcare professionals in the state can 
utilize the results of this research to improve the system attributes of timeliness and 
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completeness. Implications for positive social change included improved access to public 
health data to better understand health disparities, which could reduce morbidity and 
mortality within the population. 
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Appendix B:  Cross-Reference of Tasks and Relevant Standards for Evaluating a 
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Appendix C: Health Situation Awareness (Thacker, Qualters, & Lee, 2012) 
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